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Motility in the gastrointestinal (GI) tract is brought about by the coordinated 
contraction and relaxation of the smooth muscle (SM) layers in the walls of the GI 
tract which are in turn controlled by the underlying electrical activity of the pacemaker 
cells and smooth muscle cells (SMC). 
A mathematical model to study the relationship between the free intracellular calcium 
concentration ([Ca
2+
]i) and active contraction in gastric SMCs has been developed. 
Calcium is the interface between electrical activity and the active mechanical response 
in a SMC. An increase in [Ca
2+
]i causes contraction and a decrease causes relaxation. 
Electrical models of GI SM have studied their electrophysiological behavior and have 
simulated the membrane potential regulation, the ionic
 
current across the cell and the 
intracellular Ca
2+ 
concentration. The work presented in this thesis takes the next step of 
linking the [Ca
2+
]i to active force production. A mechanistic model that succinctly 
packages the cellular events and biochemical regulation involved in cross-bridge 
formation has been developed. 
First, contraction triggered by calcium dependent activation of Myosin Light Chain 
Kinase (MLCK) has been described in terms of two interacting modules. The first 
module describes the activation of MLCK through its interactions with calmodulin 
(CaM) and Ca
2+
, and the second module consists of a four-state scheme describing 
myosin phosphorylation and cross-bridge formation between actin and myosin.  
Comparison between model predictions with and without the cooperative binding 
between Ca
2+
, CaM and MLCK, have shown that cooperativity between binding sites 
of CaM affect the dynamics of MLCK activation. The model, when simulated with 
[Ca
2+
]i input signal recorded from canine antral SM, show the characteristic phasic 
contractile behavior observed in gastric SMCs. The model simulations match the 
experimental force behaviour during the contraction phase well, while the relaxation 
was more rapid in the experimental results.  
Next, a hypothesis of activation of Myosin light chain phosphatase (MLCP) for rapid 
relaxation has been tested and modelled.  Motivated by literature evidence that MLCP 
is regulated and activation of MLCP by a cellular protein called telokin can be 
attributed to the rapid relaxation in phasic SMCs, a formulation for Ca
2+
 and time 
dependent variation of [MLCP] has been implemented.  The results show an 
improvement in the t1/2 for relaxation with [MLCP] regulation. 
Finally, calcium desensitization has been investigated by describing two secondary 
regulatory pathways – (i) down regulation of MLCK activation through its 
phosphorylation and (ii) enhanced activation of MLCP. The secondary regulatory 
pathways act as a negative feedback control to the primary pathway described in the 
first two sections of the model. With calcium data measured from spontaneously active 
SMCs and experimentally induced abnormal calcium transients, both the amplitude 
and the temporal dynamics of force was affected by the two secondary regulatory 
mechanisms.   
The model can thus explain the triggering of active contraction by the Ca
2+
 dependent 
MLCK activation and shows the effects of secondary regulatory pathways on 
contractile behavior. By describing the downstream cellular events triggered by 
increase in [Ca
2+
]i, a framework for studying electro-mechanical coupling in gastric 
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The digestive system consists of a muscular tube called the gastrointestinal (GI) tract 
and its accessory organs. Propulsion, mixing, secretion, digestion, absorption and 
excretion of the luminal contents, are the main functions of the GI system. These 
functions are facilitated by the various motility patterns of the GI tract which are 
carried out by the coordinated patterns of contraction and relaxation in the visceral 
smooth muscle tissue under the control of sensory and motor nerves, pacemaker cells 
and endocrine or paracrine factors.  
Functional GI disorders such as gastroparesis, cyclic vomiting syndrome, delayed or 
rapid gastric emptying, dysphagia, irritable bowel syndrome and gastroesophageal 
reflux disease all involve disturbances to normal GI motility. National Institutes of 
Health (NIH) reported 60-70 million Americans to be affected each year by digestive 
diseases at a cost that exceeds $100 billion in direct medical expenses (NIH, 2009). 
Digestive diseases are associated with significant mortality, morbidity, and loss of 
quality of life. Numerous systems and processes may be impaired in GI motility 
disorders, including brain-gut interactions, the enteric nervous system, pacemaker 
activity, smooth muscle cells, pain and sensory mechanisms, the gut mucosa and 
musculature, the intestinal microflora, and immune and inflammatory responses. A 
multitude of signalling pathways and cellular proteins have been identified to regulate 
smooth muscle contractility at the cellular level. Disturbances in the pathways 
regulating the contraction, leading to abnormal contractility in smooth muscle cells, 




As with other muscle types, the primary means of generating an active contractile 
response in a SMC is through an elevation of the intracellular free Ca
2+
 concentration, 
and the primary means of elevating intracellular free Ca
2+
 is through an electrical 
depolarization of the cell membrane. This process is commonly termed electro-
mechanical coupling. Over the years, numerous studies have investigated the electrical 
behavior of the smooth muscle cells and have studied the dynamics of the intracellular 
Ca
2+ 
concentration (Vogalis et al., 1991; Kim et al., 1997). To quantitatively describe 
how the electrical activity is transduced into a mechanical output in a smooth muscle 




Experimental studies have been carried out to quantify the mechanical response of 
gastric smooth muscle under various experimental conditions both at the single cell 
and tissue levels. The roles of various cellular proteins and pathways in the regulation 
of contractility have been identified and studied in many isolated experiments. By 
integrating the knowledge and data from such experimental studies, a dynamic 
pathway model of the signal network underlying contraction and relaxation has been 
developed. It is envisaged that this mathematical model, in addition to increasing our 
understanding of the underlying mechanisms, will be able to simulate known 





1.1. Gastrointestinal System 
Structure of the GI tract: The major structures of the GI tract are the mouth, 
pharynx, oesophagus, stomach, small intestine (duodenum, jejunum and ileum), colon, 
rectum and anus (Figure 1.1). Gastric motility refers to the organized motor patterns 
uniquely suited to each organ in the GI tract that accomplish the physiological 
functions of mixing, breakdown, propulsion and expulsion of the ingested food. The 
mechanical activity of the gastric musculature plays an important role in gastric 
motility. 
 
Figure 1.1. Human gastrointestinal tract (adapted from Martini, 2006). 
 
 
The structure of the gastrointestinal tract varies from region to region, but common 
features exist in the overall organization of the tissue. Figure 1.2 depicts the layered 
structure of the stomach wall. The mucosa is the innermost layer of the GI tract and 
consists of an epithelium, the lamina propria, and the muscularis mucosae.  The 
epithelium is a single layer of specialized cells that lines the lumen of the GI tract.  In 
the stomach, the columnar epithelium contains secretory cells which secrete hormones 
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that aid in digestion. The lamina propria consists largely of loose connective tissue 
containing collagen and elastin fibrils.  It is rich in several types of glands and 
contains lymph nodes and capillaries. The muscularis mucosae is the thin, innermost 
layer of smooth muscle and contractions in these layers move the epithelial folds and 
ridges. The submucosa, which is the next layer, consists largely of dense irregular 
connective tissue. Large blood vessels and lymphatic vessels lie in the submucosa. 
The muscularis externa in general consists of two substantial layers of smooth muscle 
cells, an inner circular layer and an outer longitudinal layer. In stomach, muscularis 
externa has an extra inner oblique layer of smooth muscle cells. Contractions of the 
muscularis externa mix and circulate the contents of the lumen and propel them along 
the gastrointestinal tract. The serosa is the outermost layer of the GI tract and consists 
mainly of connective tissue and covers the entire stomach (Kutchai, 2004; Martini, 
2006). 
 
Figure 1.2. Structure of the human stomach and organization of the stomach wall 
tissue. The muscularis externa consists of two substantial layers of smooth 
muscle cells – an inner circular layer and an outer longitudinal layer and in 
stomach, it has an extra inner oblique SM layer. Contractions of the muscularis 
externa mix and circulate the contents of the lumen and propel them along the 
gastrointestinal tract (Enclyopaedia Britannica, 2003). 
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The wall of the GI tract contains many interconnected neurons. The submucosa 
contains a dense network of nerve cells called the submucosal plexus (Meissner’s 
plexus). The prominent myenteric plexus (Auerbach’s plexus) is located between the 
circular and longitudinal SM layers in the muscularis externa. These intramural 
plexuses, together with other neurons of the GI tract, constitute the enteric nervous 
system. The enteric nervous system helps to regulate the motor and secretory activities 
of the GI system. The GI tract also receives both sympathetic and parasympathetic 
innervations. The autonomic nervous system influences the motor and secretory 
activities of the GI tract by modulating the enteric nervous system (Kutchai, 2004). 
 
 
Figure 1.3. Peristalsis in the GI tract. Contraction of the circular SM layer leads 
to partial or total occlusion of the lumen and movement of the contents as seen in 
(A) and (C) and contraction of the longitudinal SM layer (B) stretches the 
stomach wall and creates cavity to accommodate the propelled contents. (adapted 
from Marieb, 2004). 
 
Peristalsis: Peristalsis is the synchronized contraction and relaxation pattern of the 
longitudinal and circular muscle layers which enables the propulsion of the luminal 
contents in the anal direction and also provides the mixing function. During peristalsis, 
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evoked by enteric nervous system in response to a bolus, contraction is evoked oral to 
the bolus and relaxation is observed anal to the bolus as shown in Figure 1.3. While 
the contraction of the circular SM layer leads to partial or total occlusion of the lumen 
and movement of the contents, contraction of the longitudinal SM layer stretches the 
stomach wall and the relaxation of the muscle layers on the anal side forms a cavity 
for the contents propelled by the oral contraction (Smith and Robertson, 1998; 
Huizinga and Lammers, 2009). 
Regulation of contraction in GI SMCs: Contraction of the gastric smooth muscle is 
controlled by its intrinsic electrical activity which is in turn regulated by the 
pacemaker cells, interstitial cells of Cajal (ICC) present in the gastric musculature. 
ICC cells cause rhythmic changes of smooth muscle cell membrane potential in the 
form of slow waves. When the slow waves depolarize the smooth muscle cell above a 
threshold, contraction is triggered. In addition to the slow waves, contraction is 
regulated and coordinated by hormones, paracrine agonists and neurotransmitters 
(Sanders and Publicover, 1993; Kutchai, 2004; Sanders et al., 2006). The regulation of 
contraction by slow waves is described in detail in Chapter 2. 
 
1.2. Smooth Muscle 
Smooth muscle cells are a major component of the cardiovascular, respiratory, 
digestive, and reproductive systems. Although there are differences among smooth 
muscles in different organs anatomically, functionally, mechanically and in their 
response to drugs, there are common features. Smooth muscle cells have dimensions 
of around 100-200 µm in length and 2 – 10 µm in diameter, and are spindle-shaped 
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(Guilford and Warshaw, 1998).  The nucleus is centrally located. The contractile unit 
of smooth muscle cell contains thin filaments composed of α- and γ-actin and thick 
filaments composed of myosin of class II isoform (Figure 1.4). Unlike striated 
muscles, the contractile filaments are not arranged in uniform transverse alignment, 
and therefore no striations are seen in smooth muscle. 
 
 
Figure 1.4. A) Organization of cell to cell contacts, cytoskeleton, and myofilaments in smooth 
muscle cells (Watras, 2004). Linkages consisting of specialized junctions functionally couple 
the contractile apparatus of adjacent cells. B) Pictorial representation of contraction and 
relaxation in a single smooth muscle cell (Martini, 2006). A single smooth muscle in relaxed 
state is spindle shaped. 
 
Smooth muscle contains intermediate filaments which form a structural backbone.  
Desmin and vimentin are two protein components of this cytoskeleton. Gap Junctions 
allow direct electrical communications between adjacent smooth muscle cells and 




cells (Horowitz et al., 1996; Watras, 2004). Smooth muscle contains no T-tubules and 





 homeostasis, generating local and global Ca
2+
 signals, and contributing 
to cellular microdomains and signaling in other organelles (Wray et al., 2010). 
Contractile elements composed of actin and myosin functionally equivalent to a 
sarcomere underlie the similarities in mechanics between smooth and striated muscles.  
Smooth muscle myosin II is a hexamer, composed of two heavy chains (≈200 kDa 
each), each having a pair of light chains, a regulatory light chain of 20 kDa (LC20) and 
an essential light chain of 17 kDa (LC17). Each of the heavy chains has a globular 
head domain at its N-terminus followed by the tail region which consists of an 
extended rod like formation of the two α helices of the heavy chains. A lever like 
swinging arm of 8.5 nm- long α helix, stabilized by the two light chains, lies between 
the globular heads and the tail region (Finer et al., 1994; Guilford and Warshaw, 
1998). Each globular head of myosin, in the form of a projection from the myosin 
filament, extends towards the actin filament (Guilford and Warshaw, 1998; Alberts, 
2002). These projections are the molecular motors that convert the chemical energy 
from the hydrolysis of ATP into mechanical work during their cyclic interaction with 
actin as shown in Figure 1.5.  
Contraction of SM cell: In smooth muscle, Ca
2+ 
is the main trigger for contraction 
(Sanders, 2008). When the concentration of intracellular Ca
2+
 increases, a series of 
events take place. The ubiquitous cytoplasmic protein calmodulin binds to Ca
2+
 ions 
in a ratio of 4:1 (Horowitz et al., 1996; Guilford and Warshaw, 1998; Watras, 2004). 
The Ca
2+
-calmodulin complex binds to a specific site on the myosin light chain kinase 
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(MLCK) converting it from the inactive form to the active form. This allows the 
MLCK to phosphorylate the regulatory light chain. 
When the regulatory light chain of myosin is phosphorylated at a specific site, Ser
19
, 
myosin undergoes a conformation change. The conformational change enables the 
interaction of myosin head with actin and activates the Mg-ATPase of myosin. When 
myosin head attaches to the actin filament, ADP and inorganic phosphate (Pi) are 
released from the myosin head allowing an ATP molecule to bind. ATP decreases the 
affinity of myosin for actin resulting in the release of myosin from actin. Mg-ATPase 
of myosin hydrolyses the newly bound ATP and the energy from the hydrolysis of 
ATP produces a conformational change in the myosin head and enables its attachment 
to actin. This is called the cross-bridge cycle and this continues as long as the myosin 
remains phosphorylated (Horowitz et al., 1996; Guilford and Warshaw, 1998; Alberts, 
2002). Force generated by the myosin-actin interaction is transmitted to the adjacent 
cells through actin filaments anchored to electron-dense bodies within the cytoplasm 
and electron-dense plaques in the cell membrane (Figure 1.4). Dense bodies contain 
the protein actinin and are functionally analogous to Z-lines in striated muscle 
(Guilford and Warshaw, 1998). With decrease in [Ca
2+
], MLCK becomes inactive and 
the cross-bridges are dephosphorylated by myosin phosphatase. Dephosphorylation of 




Figure 1.5. Regulation of smooth muscle myosin interactions with actin by Ca2+ 
stimulated phosphorylation (Watras, 2004). In the relaxed state, cross-bridges are 
present as myosin-ADP-Pi complex. Phosphorylation of myosin light chain (LC20) 
by Ca2+-calmodulin dependent myosin light chain kinase (MLCK) leads to 
change in conformation of the cross-bridge and enables its interaction with actin. 
Phosphorylated cross-bridges (colour) cycle until they are dephosphorylated by 
myosin phosphatase. Myosin phosphorylation by MLCK and cyclic interaction 




Smooth muscle contraction can be broadly classified into two types: tonic contraction 
and phasic contraction (Gregersen and Kassab, 1996; Watras, 2004). During a tonic 
contraction, the force increases and is maintained at a particular level which 
contributes to maintaining the shape of the organ against an imposed load. During a 
phasic contraction, the force increases rapidly from the baseline, reaches a peak and 
then returns back to the base line in response to the Ca
2+
 transients produced in the 
activated SM cell. GI SM exhibits rhythmic contractions i.e., phasic behavior due to 
the slow waves generated in the cell (Figure 1.6A). In GI smooth muscle, the phasic 
contractions are essentially superimposed over the basic tone of the GI SM (Murthy, 
2006). The phasic contractions lead to the observed motility pattern in GI tract. In 
some regions of the GI tract, tonic contractile behavior is exhibited (e.g., the fundus of 
the stomach) (Gregersen and Kassab, 1996). 
A smooth muscle cell shows slow and prolonged contractions compared to skeletal 
muscle which contracts and relaxes rapidly. However the ATP requirement is lower in 
SM. Hence SM has a slower action but a higher economy compared to skeletal muscle. 
Skeletal muscle has a force-velocity curve in which shortening velocities are 
determined only by load and the myosin isoform. In contrast, when smooth muscle 
activation is altered, e.g., by changing a hormone or agonist concentration, a different 
set of force-velocity curves can be obtained. This difference is due to the regulation of 
both the number of active cross bridges (determining force) and their average cycling 
rates (determining the velocity).  The number of active cross bridges is primarily 
regulated by myosin phosphorylation which is in turn regulated by the intracellular 
Ca
2+
 concentration. Though many other additional regulatory mechanisms have been 
attributed to the activation of contraction, the central mechanism in GI-SM is 
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excitation-contraction coupling in the SM (Sanders and Publicover, 1993; Somlyo and 
Somlyo, 1994; Sanders, 2008).  
 
 
Figure 1.6. Time-course of events in cross-bridge activation and contraction in 
two kinds of contractile behavior shown by smooth muscle (Watras, 2004). A) A 
brief period of stimulation leads to a Ca2+ transient which causes cross-bridge 
activation and a phasic contraction. B) In a sustained tonic contraction produced 
by prolonged stimulation, the Ca2+ and phosphorylation levels fall after reaching 
a peak. However force is maintained during the tonic contraction at reduced Ca2+ 
concentration and low level of myosin light chain phosphorylation.  
 
1.3. Motivation 
Motility at the organ level is caused by the contractile function of smooth muscle cells. 
Hence, a cellular level model for contraction would play a significant role in the 
development of tissue level and organ scale models to study gastric motility.  
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GI motility disorders 
GI motility disorders are defined by the presence of observable disturbances in the 
functioning of the smooth muscle layers or in the neuromuscular functioning of the 
enteric nervous system. Gastroesophageal reflux disease (GERD), functional 
dyspepsia, irritable bowel syndrome (IBS) and constipation represent some of the 
more common motility disorders that have a prevalence of 5-20% in the US 
population (Everhart and Ruhl, 2009). Gastroparesis, chronic intestinal pseudo-
obstruction, Hirschsprung’s disease and faecal incontinence have a lower prevalence 
but can be deleterious and can seriously affect the quality of life.   The socio-
economic burden of GI disorders has been estimated to be as significant as some of 
the life threatening diseases (Talley, 2008). 
The functional failure of smooth muscle cells leads to motility disorders of the 
gastrointestinal tract due to abnormal contractility. Pathways that regulate SM 
contractility can be broadly classified under three major types of mechanisms: 1) 
mechanisms that regulate changes in the phosphorylation of the myosin light chain, 
which is the focus of this work; 2) mechanisms that regulate the availability of actin to 
interact with myosin via the action of actin-binding proteins, and 3) mechanisms by 
which the cytoskeleton is remodelled to facilitate the transmission or maintenance of 
force developed by actomyosin interactions.  An abnormal contraction can be due to 
dysfunction of one or more factors in the smooth muscle cells. For example, any 
disturbance in electrical activity, the pathways regulating the mechanical contraction, 
or pathogen induced disturbances could result in abnormal SMC function.  
Advances in molecular studies and electrophysiology have enabled significant 
understanding of the mechanism associated with altered motility. For example, in 
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human and in animal models, intestinal inflammation results in the disturbance of 
motility and is associated with changes in SM function and/or the enteric nervous 
system (Ohama et al., 2007). Both increased and decreased SM contractility has been 
observed in intestinal inflammation. Studies show that three types of functional failure 
in SM appear to be involved in abnormal contractility: 1) changes in activity of 
muscarinic receptors, 2) changes in activity of ion channels, mainly L-type Ca
2+
 
channels and KATP channel, and 3) changes in activity of the MLC phosphatase 
inhibitor CPI-17 (Ohama et al., 2007; Ohama et al., 2008). Other mechanisms, such as 
damage to the nervous system, disruption of the ICC network and hyperplasia and 
hypertrophy of SMCs, also lead to abnormal contractility in SMCs.  
Damage to the ICC network and changes in the ion channel activity have been 
associated with the changes in the resting membrane potential, the duration and 
amplitude of slow waves. These changes in the electrical activity have been correlated 
with altered phasic contractile responses and tone generation during inflammation 
(Farrugia, 2008). A network of signalling pathways tightly couple the ion channel 
activity to the downstream force generating mechanisms.  Hence, it is important to 
study electro-mechanical coupling in SMCs to understand the regulation of 
contraction by the underlying electrical activity. 
The following table, adapted from Malykhina and Akbarali (2004), shows the impact 
of electro-mechanical coupling in causing abnormal motility during inflammation 
induced channelopathies in gastric SMCs. Malykhina and Akbarali (2004) have 
proposed that some of the clinical symptoms of altered smooth muscle contraction in 
pathogenesis of gut disorders, such as inflammatory bowel disease, may be regulated 




Figure 1.7: The chart adapted from Malykhina et al. shows the interdependence 
of the changes induced in the electrical and contractile activity and the causes for 
the clinical expression of a GI motility disorder (Malykhina and Akbarali, 2004). 
The highlighted region shows the scope of this work. (RMP-Resting Membrane 
Potential) 
 
Hence understanding the signalling cascade beginning with ICC pacemaker activity to 
the mechanical response of SMC is of great importance.  The highlighted region in 
Figure 1.7 shows the role of the model developed here within the big picture of 
understanding GI motility. 
 
1.4. Objective and Specific Aims 
The objective of the study is to develop a mathematical model to simulate the phasic 






To achieve this objective, the study is divided into three specific aims. The first aim is 
to describe Ca
2+
 dependent MLCK activation, which is the central mechanism in the 
initiation of contraction. The Ca
2+
 dependent MLCK activation is linked to myosin 
phosphorylation and the cross-bridge formation pathways to study the relationship 
between calcium and force. 
The second aim of the study is to develop a mathematical formulation for the Ca
2+
 and 
time dependent variation of MLCP. This is of particular importance to the relaxation 
phase where MLCP regulation plays an important role in the dephosphorylation of 
myosin leading to relaxation.  
The third part of the study aims to investigate the phenomenon of calcium 
desensitization using the models developed in Specific Aims 1 and 2. Two secondary 
regulatory pathways – a) MLCK phosphorylation and b) enhanced activation of 
MLCP are modelled and their effects on the calcium-force relationship are also 
studied. 
 
1.5. Thesis Overview 
The underlying theme of the thesis is that intracellular Ca
2+
 is the interface between 
electrical activity and active contraction in smooth muscle cells, and by 
mathematically describing the cellular events involved in the Ca
2+
 dependent 
contraction, a framework to study electro-mechanical coupling can be developed.  The 
thesis focuses on the development of a quantitative description of the contraction and 






The objective and the specific aims of the study are listed in the following section 
(Section 1.4) and the motivation for the study is explained in Section 1.5. A literature 
review on the electrical and mechanical properties of the smooth muscle, experimental 
studies on the contraction of gastric smooth muscle and various modelling work 
related to the study is reported in Chapter 2. Intracellular calcium is the main link 
between the electrical activity and contraction in smooth muscle. In Chapter 3, a 
model for the calcium dependent signalling of active contraction in gastric smooth 
muscle is presented. In Chapter 4, modelling of the regulation of relaxation is 
described. Chapter 3 and Chapter 4 together present the model to describe the phasic 
contractile behavior in a gastric smooth muscle cell. The model has been validated 
against experimental data and predicts the relationship between intracellular calcium 
concentration and active force in the gastric smooth muscle. In Chapter 5, a model for 
experimentally observed phenomenon called calcium desensitization in phasic smooth 
muscle is reported. While Chapter 3 and Chapter 4 focus on the primary mechanism 
of contraction, in Chapter 5 the model shows the role of two secondary regulatory 




2. Literature Review 
2.1. Electrical Basis for Gastric Motility 
2.1.1. Electrophysiology of GI Smooth Muscle 
Interstitial Cells of Cajal (ICC) 
As described in Chapter 1, the wall of the gastrointestinal tract contains two muscle 
layers: a thin outer longitudinal layer and an inner thicker circular muscle layer. The 
intrinsic electrical activity of the gastric SMC layers is attributed to the presence of 
pacemaker cells called ICC. Slow waves generated by ICC are spread through the ICC 
network and from ICC to SMCs via gap junctions. Two types of ICC have been 
identified based on their location. In between the circular and longitudinal SMC layers, 
ICC are found in the myenteric plexus (ICCMY). The second set of ICC, ICCIM are 
found amongst the SMCs of the circular layer.  ICCMY are responsible for the active 
generation and propagation of slow waves throughout the gastric musculature.  ICCIM 
mediate the pathway between enteric nerve terminals and smooth muscle cells and 
also play a role in the propagation of slow waves (Szurszewski, 1987; Hirst and 
Edwards, 2006; Sanders et al., 2006). While mutant mice lacking ICCMY failed to 
generate slow waves, mutant mice containing ICCMY but lacking ICCIM generate 
incomplete slow waves and fail to respond to excitatory or inhibitory nerve 
stimulation unlike the wild type mice (Szurszewski, 1987; Hirst and Edwards, 2006). 




Figure 2.1. ICC-SMC network in stomach. ICCIM can be seen interspersed within 
the SMCs of the circular layer. Slow wave from the corpus depolarizes the 
ICCMY network in the antrum and triggers a pacemaker potential as shown. Each 
driving/pacemaker potential propagates anally through the ICCMY network. The 
circular SM bundles get depolarized and antral ICCIM are activated and the 
regenerative component of the slow wave is generated. The regenerative 
potential rapidly conducts circumferentially and depolarizes nearby smooth 
muscle cells triggering a ring of contraction. Figure modified from Hirst et al. cf. 
(Hirst et al. Figure 4) (Hirst and Edwards, 2006).  
 
Slow waves 
The stomach generates a characteristic pattern of coordinated electrical activity which 
forms the basis for its motility. The successive descending rings of contraction in the 
stomach are triggered by waves of electrical activity known as slow waves (Figure 2.2) 
which originate in the corpus and migrate slowly down the stomach to the duodenum 
(Kutchai, 2004; Martini, 2006). Intracellular recordings from different regions of the 
stomach, as shown in Figure 2.3, indicate that all regions, except the fundus generate 




Figure 2.2. Experimental recording of slow wave obtained from a canine 
gastric SM strip (Ward et al., 2004). 
 
In the fundus and sphincters, electrical activity is characterized by slow tonic changes 
in membrane potential. Most other regions of the GI tract have phasic electrical 
activity in the form of slow waves. The frequency of slow waves depends on the 
section of the GIT and is usually reported as cycles per minute (cpm). In the normal 
human stomach it is 3 cpm and the frequency is highest at 11-13 cpm in the duodenum 
but declines along the length of the small intestine to 8 cpm in the terminal part of the 
ileum. The amplitude and, to a lesser extent, the frequency of the slow waves are 
modulated by the activity of the intrinsic and extrinsic nerves and by hormones and 
paracrine substances (Szurszewski, 1987; Kutchai, 2004).  
Slow waves are found to be triphasic in the antrum. As can be seen in Figure 2.2 and 
Figure 2.3, the slow wave has an initial depolarization phase and after reaching a peak 
and quick repolarization, plateau phase is maintained. Later the membrane potential 
falls to the resting membrane potential and forms the repolarization phase. Neural and 
hormonal control in organs like small intestine and colon trigger action potentials. 
They are superimposed on the basal slow wave.  When the membrane potential of a 
GI SM cell nears the peak of a slow wave, a train of action potentials may be fired. 
The extent of depolarization of the cells and the frequency of action potentials are 
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influenced and enhanced by neurotransmitters (e.g., acetylcholine) and agonists (e.g., 
gastrin). Inhibitory hormones and neuroeffector substances (e.g., norepinephrine) 
hyperpolarize the SM cells and may diminish or abolish action potential spikes 
(Szurszewski, 1987; Kutchai, 2004). 
 
Figure 2.3: Intracellular recordings of the electrical activity in SM of isolated 
strips of various regions of a dog’s stomach (Kutchai, 2004). Slow waves are 
absent in the fundus and weak in the orad corpus, and gain in strength and 
definition toward the antrum. The action potentials on the plateaus of the slow 






SMCs have a negative resting membrane potential determined by the relative 
permeabilites of the plasma membrane to physiological ionic species.  SMCs 
demonstrate dominant permeability to K
+
 ions. However there is contribution from 




 pump also 
contributes to the resting potential. Resting membrane potentials of GI SMC in 
different regions of the gut vary widely from -85 mV to -40 mV (Sanders and 
Publicover, 1993).  Regulation of the resting membrane potential preconditions the 
responses of SMC to depolarizations from the pacemaker cells and agonists. 
Depolarization leads to increase in open probability of voltage dependent Ca
2+
 
channels (VDCC) and result in the influx of Ca
2+
 (Figure 2.4). The increase in 
intracellular Ca
2+
 is the main trigger for contraction in GI SMCs as explained further 
in detail in Section 2.1.2. Contraction is caused by the increase in [Ca
2+
]i and these 
cells relax when there is a decline in [Ca
2+
]i. Excitatory agonists increase the 
amplitude of depolarizations and cause increased Ca
2+
 entry. Inhibitory agonists 
reduce the depolarization amplitude reducing the magnitude of Ca
2+
 entry and hence 
reducing the force of contractions. The modulation of the amplitude of slow waves of 
the cell results in a range of contractile amplitudes. 
Figure 2.3 shows the intracellular recordings of the electrical activity in SM cells of 
isolated strips of various regions of a stomach. When a wave of oesophageal 
peristalsis begins, a reflex causes the lower oesophageal sphincter (LES) to relax. This 
relaxation of the LES is followed by receptive relaxation of the fundus and body of 
the stomach. The stomach relaxes to accommodate the bolus of food. The nerve fibers 
mediate the reflex relaxation of the stomach by releasing transmitters such as 
vasoactive intestinal peptide (VIP) and/or nitric oxide (NO). The muscle layers in the 
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fundus and body are thin and, due to the absence of slow waves, only weak 
contractions are seen in these parts. As a result, the contents of the fundus and the 
body settle into layers based on their density. Gastric contents can remain unmixed for 
as long as one hour after eating. The contractions usually begin in the middle of the 
body of the stomach and travel toward the pylorus. They increase in force and velocity 
as they approach the gastro-duodenal junction. Thus, the major mixing activity occurs 
in the antrum of the stomach. The electrical activity in the antrum (shown in Figure 
2.3) corresponds to forceful and rapid contractions.  The more rapid contractions at 
the terminal antrum propel the chyme back into antrum when the pyloric sphincter is 
closed (retropulsion) and push the chyme into the duodenum when the pyloric 
sphincter is open. The electrical activity of the SM and the mechanical response 
(contraction and relaxation) through electro-mechanical and pharmaco-mechanical 
coupling facilitate the motility functions of the GI system (Kutchai, 2004). 
 
2.1.2. Excitation-Contraction Coupling 
The signalling for the contraction and relaxation of gastric SM cells can be through 
two forms of excitation-contraction coupling: electromechanical coupling and the 
pharmaco mechanical coupling (Sanders and Publicover, 1993; Bolton et al., 1999; 
Sanders, 2001; Sanders, 2008). An increase in the intracellular calcium concentration 
is the main trigger for excitation-contraction coupling in GI SMCs. Figure 2.4 shows 
the important cellular mechanisms that determine the intracellular calcium level.  
In electromechanical coupling, changes in the smooth muscle membrane potential 
lead to contraction. Changes in the membrane potential, in the form of slow waves, 
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lead to an increase in the intracellular Ca
2+
 level by inflow from the extracellular 
space via voltage operated Ca
2+
 channels on the plasma membrane of the cell as 
shown in Figure 2.4 (Carl et al., 1996). The increase in [Ca
2+





release from sarcoplasmic reticulum.
 
 L-type (slow) Ca
2+
 channels and 
T-type (fast) Ca
2+
 channels are the prominent voltage dependent calcium channels 





 channels are also calcium sensitive. A few receptor operated 
channels such as the ligand-operated G-protein dependent K-channel and ligand-
operated ATP-sensitive K-channel, can also change the membrane potential. The 
change in membrane potential secondarily opens or closes voltage-dependent Ca
2+ 
channels to cause contraction or relaxation respectively (Guyton and Hall, 1996; 
Watras, 2004). 
Gastric SM contracts only when the depolarization during the slow wave exceeds the 
threshold for contraction. Below the threshold, slow wave does not elicit contraction. 
The greater the extent of depolarization and the longer the muscle cell remains 
depolarized above the threshold, the greater is the force of contraction. The action 
potentials evoke much stronger contractions compared to slow waves that are not 
accompanied by action potentials. The individual action potentials in a train do not 
cause distinct twitches as in skeletal muscle; rather they sum temporally to produce a 
smooth increase in the muscle tension as can be seen in Figure 2.5. Ca
2+
 influx during 
action potentials initiates large amplitude contractions and propulsive contractions in 





Figure 2.4. Principal mechanisms determining the cytoplasmic [Ca2+] in smooth 
muscle cell (Watras, 2004). G – Guanine nucleotide binding proteins; ATP- 
Adenosine triphosphate; PLC- phospholipase C; PIP2- Phosphotidylinositol 
biphsophate; IP3 – Inositol 1,4,5-trisphosphate; CM- Calmodulin; MLCK- 
Myosin light chain kinase. 
 
Between each slow wave, the intracellular Ca
2+
 levels and the tension developed by 
GI SM fall but not to zero. This nonzero resting, or baseline, tension of smooth muscle 
is called tone (Figure 2.5). In GI SM, the phasic contractions are essentially 





Figure 2.5. Pictorial representation the relationship between membrane potential 
and contraction of SM. SM contracts when the depolarization during the slow 
wave exceeds the threshold for contraction. The action potentials evoke much 
stronger contractions compared to slow waves that are not accompanied by 
action potentials (Kutchai, 2004).  
 
In pharmacomechanical coupling, chemicals or agonists such as neurotransmitters 
and hormones cause excitation-contraction coupling in SM through multiple cellular 
signalling mechanisms that can influence the level of force without a necessary 
change in membrane potential (Somlyo and Somlyo, 1994; Horowitz et al., 1996). In 
this situation, activated receptor operated channels directly affect the contractile 
machinery through G-proteins and second messengers. The second messengers can 
lead to a rise in [Ca
2+
] through receptor operated Ca
2+
 channels on the plasma 
membrane of the cell or from the sarcoplasmic reticulum via inositol triphosphate (IP3) 
receptor operated Ca
2+
channels, as shown in Figure 2.4, and activate contraction.  
Contraction through calcium independent mechanisms and modulation of the 
sensitivity of force to Ca
2+
 are other major mechanisms of pharmaco-mechanical 
coupling (Sanders, 2008). Both the amplitude of phasic contractions and the tone are 
altered by neuroeffectors, hormones, paracrine substances and pharmacological agents 
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(Sanders and Publicover, 1993; Bolton et al., 1999; Kutchai, 2004; Murthy, 2006; 
Sanders, 2008).  
During electro-mechanical coupling, pharmaco-mechanical mechanisms can be 
activated through second messengers and during pharmaco-mechanical coupling, 
opening of ligand gated channels can result in hyperpolarization, depolarization or no 
change in membrane potential (Bolton et al., 1999). Thus excitation caused by a single 
agent may be the result of either electro-mechanical coupling or pharmaco-mechanical 
coupling, or a combination of both. Both calcium dependent and calcium independent 
mechanisms can operate simultaneously in a given SM cell to cause contraction 
(Harnett and Biancani, 2002; Vladimir Ganitkevich, 2002).  
 
2.2. Signalling for Contraction and Relaxation in Gastric Smooth 
Muscle 
An increase in the concentration of cytosolic free Ca
2+ 
is the primary trigger for the 
contraction of smooth muscle. When the intracellular Ca
2+
 levels increases, it binds to 
the ubiquitous cytoplasmic protein calmodulin in the ratio 4:1. Binding of four Ca
2+
 
ions to calmodulin induces allosteric changes in calmodulin. The conformational 
change in calmodulin enables it to bind to its target proteins. Myosin light chain 
kinase, a high affinity target protein of calmodulin, gets activated upon its binding to 
calmodulin. Activation of MLCK leads to phosphorylation of Ser
19
 on the 20 kDa 
regulatory light chain of myosin II (MLC20), activation of actin activated myosin 
ATPase and the interaction of actin and myosin which initiates contraction (Sanders 
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and Publicover, 1993; Somlyo and Somlyo, 1994; Horowitz et al., 1996; Murthy, 
2006). 
Relaxation of smooth muscle is associated with low intracellular calcium 










exchanger and sarcolemmal Ca
2+ 
ATPase, and by reuptake by the sarcoplasmic 
reticulum using the sarcoplasmic reticulum’s membrane ATPase. The decreasing 
concentration causes the dissociation of the Ca
2+
/Calmodulin/MLCK complex and 
inactivation of the kinase. The phosphorylated myosin light chains are 
dephosphorylated by myosin light chain phosphatase (MLCP) and muscle relaxation 
takes place (Somlyo and Somlyo, 1994; Horowitz et al., 1996; Murthy, 2006).   
In the presence of agonists, G-protein dependent cellular events augment contractile 
activity at fixed Ca
2+
 concentrations.  Agonists activate Gq-coupled receptors and 
phospholipase C (PLC), and lead to generation of IP3 (Inositol triphosphate). The IP3-
dependent Ca
2+
 release through IP3 receptor channels elevates intracellular Ca
2+
 and 
activates contraction through Ca
2+
-CaM dependent MLCK (Somlyo and Somlyo, 
1994; Horowitz et al., 1996). In pharmaco-mechanical coupling, agonists also induce 
contraction through regulated inhibition of MLCP and other calcium independent 
mechanisms. Rho kinase and Protein Kinase C (PKC) are known to inhibit MLCP 
(Murthy, 2006). The inhibition of MLCP leads to increased levels of myosin 
phosphorylation and a sustained contraction of the smooth muscle. After activation by 
diacylglycerol (a second messenger), PKC activates thin filament associated proteins, 
calponin or caldesmon via the Ras/Raf/MEK/MAPK phosphorylation cascade, and 
plays a role in smooth muscle contraction (Morgan and Gangopadhyay, 2001). cAMP-
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dependent relaxation by β-adrenergic agonists, adenosine and PGI2 (Ozaki et al., 1992) 
and cGMP-dependent relaxation by NO are some of the other Ca
2+
 independent 
mechanisms of SM activation reported in the literature (Guyton and Hall, 1996; 
Watras, 2004). 
Thus, the signalling reactions involved in smooth muscle contraction can be broadly 
classified under electro-mechanical coupling pathways and pharmaco-mechanical 
coupling pathways, based on the type of signal that initiates the contraction. In this 
study, the focus is on the spontaneous contractions due to slow waves in the absence 
of any kind of external agonist stimulation. In this scenario, the reactions pertaining to 
the electro-mechanical coupling pathway are the primary reactions involved in SM 
contraction. Hence pharmaco-mechanical coupling pathways signalled by agonists 
and Ca
2+
 independent SM contraction are not the focus of this study. 
The scope of the study is electro-mechanical coupling. The electrics part of the 
electro-mechanical coupling has been investigated and modelled already (Corrias and 
Buist, 2007; Corrias and Buist, 2008). The electrical models predict the dynamics of 
intracellular Ca
2+
 concentration for a given change in the membrane potential. Hence 
the study here focuses on the mechanical part of electro-mechanical coupling by 







Figure 2.6. Schematic representation of major pathways involved in excitation-
contraction coupling in GI smooth muscle by Sanders (Sanders, 2008). The 
diagram shows the mechanisms involved in both electro-mechanical coupling 
and pharmaco-mechanical coupling. Ca2+ entry through VDCC is the primary 
mechanism in electro-mechanical coupling. 
 
2.3. Calcium, Myosin Phosphorylation and Force 
Yagi et al. (1988) studied the relationship between force and the Ca
2+
 concentration in 
single smooth muscle cells isolated from the stomach of the toad Bufo marinus. Both 
[Ca
2+
]i and force were measured after maximal electrical stimulation. The calcium 
threshold for the elevation of force was reported to be 125-150 nM. The maximum 
sensitivity of force to Ca
2+
 was observed in the Ca
2+
 range between 150 and 500 nM. 
The study showed a delay of several hundred milliseconds between electrical 
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stimulation and the onset of force, and this delay was attributed to the steps involved 
in the activation of the contractile apparatus within the cell.  A delay was also 
observed between stimulation and myosin phosphorylation. This led the authors to 
associate the delay to the steps linking Ca
2+
 and light chain phosphorylation. The rate 
of increase in force was dependent on the rate of Ca
2+
 elevation until a maximum Ca
2+
 
concentration of 1 µM, beyond which there were only small changes in force.  
Ozaki et al. (1991b) made simultaneous measurements of membrane potential, 
cytosolic Ca
2+
 and tension in intact canine antral smooth muscle strips to study the 
change in [Ca
2+
]i during slow waves and see if the Ca
2+
 levels reached during slow 
waves were capable of eliciting contractions.  Figure 2.7 shows recordings of 
spontaneous slow wave activity from canine antrum smooth muscle, the associated 
Ca
2+
 transients and muscle tension (Ozaki et al., 1991b). 
The increase in force occurred approximately 0.3 s after initiation of the Ca
2+
 transient. 
The muscle tension reached a maximum after the maximum increase in Ca
2+
 was 
achieved. However muscle tension decreased more rapidly than Ca
2+
 indicating the 
role of an inactivation process in the regulation of the contractile activity. The paper 
reported the antral contractions appear to be biphasic, the first phase occurring in 
response to the upstroke of the slow wave and the second phase being dependent on 





Figure 2.7. (A) Recordings from canine antrum smooth muscle strip showing 
spontaneous slow-wave activity (MP), cytosolic [Ca2+] (shown as fluorescence 
F400/F500 ratio), and muscle tension. (B) Superposition of membrane potential, 
[Ca2+] (F400/F500 ratio) and tension (Ozaki et al., 1991b). 
 
Szurszweski (1987) hypothesized that the first contractile phase is generated each time 
a slow wave propagates through the muscle and is not affected by inhibitory or 
excitatory agonists.  The second phase is not always present and its amplitude can be 
varied by different excitatory and inhibitory agonists. If a minimum plateau level, 
called the ‘mechanical threshold’ is not reached, the second phase of contraction was 
undetectable. The mechanical threshold for excitation-contraction coupling was 
detected at a membrane potential between -60 and -40 mV. The plateau phase of the 
slow wave caused a sustained influx of Ca
2+
 and when the Ca
2+







concentration above the threshold for contraction, a second phase of contraction is 
initiated. Ozaki et al. (1991b) showed that the Ca
2+
 during the upstroke and the 
associated contraction was not significantly affected by acetylcholine and hence not 
regulated by cholinergic stimulation. Acetylcholine was shown to cause a 
concentration dependent increase in the magnitude of the second phase of the Ca
2+
 
transient and muscle tension as shown in Figure 2.8.  
 
 
Figure 2.8.  Concentration dependent effect of Acetylcholine (ACh) on slow 
waves, [Ca2+], and tension from (Ozaki et al., 1991b). Control recordings are 
superimposed with responses to three concentrations of acetylcholine denoted by 
asterisk: 10-7 M (A), 3 x 10-7 M (B) and 10-6 M (C). Magnitude of the second 




2.4. Smooth Muscle Contraction Modelling Review 
To understand and quantify how [Ca
2+
]i signal is transduced into a mechanical force 
output, and ultimately motility, it is necessary to understand the cellular processes that 
take place when such a signal is received. A number of theories and models have been 
proposed to explain smooth muscle contraction. A literature review on the models that 
are relevant to the current work is reported in this section.   
 
2.4.1. Hill’s Model 
Hill (1938) proposed a model to explain the mechanical behavior of the skeletal 
muscle.  Hill’s model (Figure 2.9) represents an active muscle as composed of three 
elements. Two elements are arranged in series: a) a contractile element which has zero 
tension, but when activated is capable of shortening; b) an elastic element in series 
with the contractile element. The third component is an elastic element in parallel to 
the contractile element and series elastic element. 
The active state of the contractile component was defined by Hill’s characteristic 
equation, 
                     , (2.1) 
 
where T represents tension in the muscle, v represents the velocity of contraction, and 







           
Figure 2.9: (A) Three Component Model. (B) The properties of the contractile 
component are determined from its force-velocity curve, and the properties of the 
series elastic component are determined from its force-extension curve (Hill, 
1938; Fung, 1993). 
 
 
The contractile component represents the contractile element of the muscle. In the 
later years the contractile element was identified to contain the actin and myosin 
molecules and the active contraction was described by the formation of cross-bridges 
between actin and myosin. The series elastic component is essentially a spring that 
represents the contribution of the intrinsic elasticity of the contractile elements and 
other tissue components in active tension generation. The passive elastic component in 
parallel represents the potential energy stored in relaxed state of the muscle when it is 
stretched beyond its natural resting length. This is due to passive elastic structures 
such as the connective tissue. The contractile component is considered to be ‘freely 
extensible’ and is activated at the onset of active contraction.  Hence, the series elastic 
element carries no load at the resting (or relaxed) state. The properties of the resting 
muscle and its contribution to tension was described by the parallel elastic component. 




components. Although the model was proposed for striated muscle, it has been 
adapted to study smooth muscle too (Gestrelius and Borgstrom, 1986). Hill’s model 
provided a basis for explaining the contractile function of skeletal muscle under 
various conditions (e.g., isometric, isotonic contractions).  In the later years, models 
adapted and modified Hill’s three component model to accommodate the experimental 
findings in the field of smooth muscle mechanics (Gestrelius and Borgstrom, 1986).  
 
2.4.2. Huxley’s Sliding Filament Model 
According to Huxley’s Sliding Filament Model (Huxley, 1957), muscle contraction is 
caused via myosin and actin filaments sliding past one another by the combination of 
sites projecting from the myosin backbone of the thick filament and active sites on the 
actin thin filament. The process was presumed to be cyclic with repetitive attachment 
and detachment of cross-bridges. 
 
Figure 2.10. The figure shows the tension-generating mechanism in Huxley’s 
model. M- Cross bridge; O- equilibrium position; A-active site on the actin thin 




Huxley’s theory was based on three basic premises – (i) Cross-bridges can exist only 
in two states: attached or detached; one ATP molecule is split when a cross-bridge 
passes in sequence through these states, (ii) cross-bridges exert force only when 
attached and the magnitude of that force depends on the displacement of the thick and 
thin filaments with respect to each other and the distance between active sites on the 
thin filament (to which the cross bridges can attach) is assumed to be large enough 
that only one site at a time is within range of the myosin head, and (iii) rate constants 
for the transition between the states are functions of the relative displacement of thick 
and thin filaments. The rate constants were chosen such that the cross bridges attach 
more readily at positive displacements than at negative displacements, with the 
converse holding true for detachment. 
 
2.4.3. Gestrelius and Borgstrom’s Model for SM Contraction 
Gestrelius and Borgstrom (1986) proposed a model based on Huxley’s sliding 
filament theory and Hill’s three component model, and developed a dynamic model 
for the contraction of vascular smooth muscle. The model was parameterized using 
experiments on vascular smooth muscle from the rat portal vein. The Gestrelius-
Borgstrom model (Figure 2.11A) has four elements: (i) an active contractile 
component, which comprises the actin and myosin filaments of the SM; (ii) an elastic 
component coupled in series with the contractile component; (iii) an external elastic 






    
Figure 2.11. (A) Dynamic Model for Vascular SM contraction proposed by 
Gestrelius and Borgstrom (1986). cc- contractile component; x, hc, d, and l are 
lengths; Fcc, FS, FP, and FT denote forces and ks , kc  and kp are stiffness of the 
components. (B) Schematic diagram of the friction clutch assumption used in the 
model. 
 
The mathematical equations in the Gestrelius and Borgstrom model describe the 
different properties of the smooth muscle under the two major categories of active 
force production and passive properties of the SM. The active force production was 
described through friction-clutch mechanism (Figure 2.11B). It was assumed here that 
the transfer of energy and force from the active cross-bridges to the actin filaments 
can be described by a ‘friction clutch’ mechanism and was described by the following 
ordinary differential equation. 
                      (2.2) 
 
where Fcc is the active force of the contractile component, nc is a normalized factor 
reflecting the maximum number of cross-bridges available for interaction at a certain 
degree of activation, fc is a measure of force interaction between the cross-bridges and 




is the resulting contraction velocity of the muscle. The length-active force relationship 
was described by, 
                        (2.3) 
 
Here an and bn are constants; l is the actual length of the muscle and l0 is the optimum 
muscle length. 
Assuming a linear cross-bridge elasticity, the total force sustained by the cross-bridges, 
which must equal the total active force Fcc, was described by the following relation. 
               (2.4) 
 
Here nc is the normalized number of cross-bridges available for interaction, kc is the 
stiffness of a cross-bridge and hc is the average cross-bridge extension. 
The important contribution of the model was the external series elasticity that 
accounts for the compliance of the muscle which cannot be solely attributed to the 
cross-bridges. This was not addressed by the classic Hill Model (Hill, 1938).  The 
model has attempted to address extensively the various properties of smooth muscle 
under both active and passive conditions. The force-velocity relationship, length-
passive force and length-active force relationships, and the relationship between 
number of active cross bridges and isometric force are the important predictions made 
by the model. The model predicts a non-hyperbolic force-velocity relationship under 
high force conditions and is able to maintain isometric force under conditions of a 
reduced maximum contraction velocity as shown in Figure 2.12.  These are the 
features that differentiate smooth muscle mechanics from skeletal muscle mechanics 
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as explained by the classic Hill model. The active force production in the muscle was 
described by a frictional clutch mechanism (shown in Equation 2.7) which represents 
the transfer of energy and force from the active cross-bridges to the actin filament. 
Due to the large number of active cross bridges in a muscle, their combined action 
was adequately described by an average cross-bridge function. 
The model proposed by Gestrelius and Borgstrom describes both the active and 
passive components of smooth contraction and takes into account the mechanical 
properties of the SM. The model emphasizes active contraction in terms of myosin 
interactions with actin, the number of active cross-bridges, and the velocity of cross-
bridge displacement. However the model gives only a basic description of the 
contractile component. The model’s parameters have been fitted using experimental 
studies on SM from the rat portal vein, which primarily shows tonic contraction and 
linear correlation between active force and the number of cross-bridges was 
prescribed by the model (Figure 2.13). The model does not include any biochemical 














Figure 2.12. (a) Comparison between the force-velocity curve of the model (solid 
line) and a Hill equation (dashed line) based on average parameters of seven 
portal veins; (b) Comparison of active force-time relationships between model 
prediction (solid line) and AC stimulated hog carotid SM (dashed line), assuming 
the same force-velocity curve (dotted line) in the model simulation as in the in 





Figure 2.13 Relationship between the number of active cross-bridges, nc/no and 






2.4.4. Hai and Murphy’s Four-state Model 
Hai and Murphy (1988) developed one of the first models that explain active force 
production in SM cells through myosin phosphorylation and cross-bridge formation. 
The model consists of four states of myosin leading to the attachment to and then 
detachment from actin. The model hypothesizes that there are two types of cross-
bridge interactions: cycling phosphorylated cross-bridges (AMp) and non-cycling 
dephosphorylated cross-bridges, called latch-bridges (AM). These are regulated by the 
phosphorylation and dephosphorylation of myosin molecules, the cycling rates of the 
cross bridges and the formation of latch bridges. According to the model, both AMp 
and AM contribute to the development of stress in SM. A schematic representation of 
the four- state model is shown in Figure 2.14. 
 
Figure 2.14. Four-state cycling cross bridge model proposed by Hai and Murphy 
(Hai and Murphy, 1988). A- Actin; M- Myosin; Mp – phosphorylated myosin; 
AMp – cross-bridge and AM – latch bridge. K1-7 are the rate constants. 
 
From Figure 2.14, the mathematical formulation of the model was constructed as a set 
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Solving Equations 2.10 - 2.13, total phosphorylated myosin was calculated as the sum 
of Mp and AMp. Stress was described as the sum of AMp and AM and was 
normalized to a maximum value which was assumed to be 80% of total myosin 
concentration. 
 
Figure 2.15. The figure shows the fitting of the myosin phosphorylation and 
stress curves from the Hai and Murphy model to the experimental data shown in 





Figure 2.16. Time course of force, myosin phosphorylation and maximum 
shortening velocity (Vo) in neutrally stimulated strips of tracheal smooth muscle 
(Kamm and Stull, 1985). 
 
The model was based on the hypothesis that myosin phosphorylation is both necessary 
and sufficient for the development of stress. This hypothesis has been incorporated 
into the model by the activation of MLCK as the only regulated mechanism and the 
regulation was modelled by choosing different parameter values for K1, corresponding 
to the transient increase in Ca
2+ 
as shown in Figure 2.15. The latch state hypothesis 
has been implemented by postulating the transformation of AMp to AM to explain the 
basic observation of stress maintenance with low myosin phosphorylation (Dillon and 
Murphy, 1982). Thus, the model, by considering two different attached cross-bridge 
states, constant cross-bridge cycling rates and only one regulatory mechanism, has 
proposed a simple hypothesis to explain the development of stress and steady state 
stress maintenance in smooth muscle. The parameters were determined by fitting the 
model to experimental data shown in Figure 2.16. An alternative theory of variable 
cycling rates would have required more than one regulatory or control mechanism 
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(Warshaw et al., 1988; Paul, 1990; Hellstrand and Nordstrom, 1993).  Since the model 
was able to predict the stress and phosphorylation patterns quantitatively and also the 
energetics data qualitatively, the simple formulation was considered sufficient. Model 
simulations predicted a hyperbolic dependence of steady state stress on myosin 
phosphorylation, which corresponded with the experimental observation of high 
values of stress with low levels of phosphorylation in intact tissues (Kamm and Stull, 
1986). The authors also claimed that from the model simulations it is evident that the 
initial phosphorylation transient only accelerates stress development, with no effect on 
the final steady state levels of stress.   
However, the Hai and Murphy model has its limitations. One of the main limitations is 
that although the transient activation of MLCK is reported to be due to the transient 
intracellular Ca
2+
 levels, no direct relationship between the Ca
2+
 concentration and 
MLCK kinetics was included. The transient behavior was implemented as a step 
change in K1 value fitted to the experimental data. The model was developed based on 
the experimental studies from swine carotid media which exhibits mainly tonic 
activity and thus has limited applicability to a phasic smooth muscle. 
 
2.4.5. Bursztyn et al.’s Uterine SM Model 
Bursztyn et al. (2007) developed a model for excitation-contraction coupling in a 
uterine smooth muscle cell based on the four-state model of Hai and Murphy. The 
four-state model was coupled to the Ca
2+
 concentration through the rate constant for 
myosin phosphorylation. The rate constant of myosin phosphorylation, K1, was 





       
        




Here Cahalf_max is the calcium concentration required for half maximal activation of 
MLCK by Ca
2+
/CaM and n is the Hill coefficient of activation.  The parameters 
(Cahalf_max and n) of Equation 2.14 and other constants in the four state model, K2, K3 
and K7, were estimated by fitting to experimental data from uterine smooth muscle 
(Word et al., 1994).  The model described a sigmoidal relationship between MLCK 
activity and Ca
2+
 concentration as observed experimentally (Geguchadze et al., 2004). 
The sigmoidal relationship showed three characteristics of MLCK activation behavior 
in the smooth muscle cell: i) below the threshold Ca
2+
 concentration, there is minimal 
activation of MLCK; ii) a steep relationship between MLCK activation and Ca
2+
 
concentration can be observed in the optimal Ca
2+
 range and iii) at higher Ca
2+
 
concentration desensitization due to phosphorylation of MLCK reduces its activation.  
The model shows a good correlation between the predicted force and the experimental 
force for conditions of increasing Ca
2+
 concentration (Figure 2.17). However, under 
phasic Ca
2+
 transient conditions, although the authors claim a good correlation with 
the experimental results, the rate of force development is slower in the model 
compared to the force behavior shown by experiments (Word et al., 1994).  The rate 
of relaxation is also lower and the force does not fall to resting levels. Force reaches a 
steady state above the resting level and this can be attributed to the description of the 




Figure 2.17. Bursztyn et al.’s model: Simulation of myosin light chain (MLC) 
phosphorylation (A) and force production (B) in human nonpregnant 
myometrium in response to an increase in CCa,i (C), which was used as an input 
for the simulation. Experimental data of CCa,i, MLC phosphorylation, and stress 
are shown as open circles. (Bursztyn et al., 2007) 
 
2.4.6. Lukas’ Model 
Lukas (2004a and 2004b) developed a cell signalling model beginning at the 
activation of plasma membrane receptors by agonists and ending with myosin 
phosphorylation. Agonist induced receptor activation, Ca
2+
 mobilization, and 
activation of MLCK leading to myosin phosphorylation was modelled on the Virtual 
Cell platform (Loew and Schaff, 2001). The model consists of an extensive pathway 
that includes calcium-calmodulin binding, activation of MLCK, regulation of MLCP 
by agonists, phosphorylation and dephosphorylation of myosin (Figure 2.18). The 
model also includes CaM buffering and MLCK phosphorylation reactions. The model 
predicts the amount intracellular calcium and myosin phosphorylation for a given 
agonist concentration. The model showed the amplitude of myosin phosphorylation 
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and the time taken to reach the maximum value to be dependent on the agonist 
concentration.  The model also showed that agonist induced MLCP inhibition 
increases myosin phosphorylation levels. The model elucidates the cell signalling 
processes in a generic smooth muscle cell. Though the model includes primary and 
secondary pathways in the regulation of myosin phosphorylation, the model does not 
take into account the differences in the type of smooth muscle (phasic and tonic) and 
the results are not validated against experimental data. The model is more useful for 
studying, the downstream events in a signalling cascade due to receptor activation by 
agonists. 
 
Figure 2.18. The pathway of myosin light chain phosphorylation and 
dephosphorylation through the dynamic regulation of MLCK and MLCP 




Although the Lukas model describes the reactions regulating contraction that are 
common across SM types and provides a pathway framework for SM contraction that 
can be modified or extended, the model is not specific to a particular type of SM. The 
focus of Lukas model is the pharmaco-mechanical pathways stimulated in response to 
agonists. 
2.4.7. Mbikou et al. Model 
Fajmut et al. (2005a) and Mbikou et al. (2006) have derived a theoretical model 
describing the interaction between calcium, calmodulin and MLCK in a smooth 
muscle cell and studied the relationship between free calcium concentration and 
MLCK activation.  The theoretical model consists of eight different species with 
twelve reactions in the pathway leading to the formation of the active MLCK complex. 
The theoretical model was coupled to the four state Hai and Murphy model to study 
the contraction of airway smooth muscle model as shown in Figure 2.19 (Fajmut et al., 
2005b; Fajmut et al., 2005c; Mbikou et al., 2006; Fajmut and Brumen, 2008).  The 
model showed a reasonable correlation to experimental observation with respect to the 
steady state sigmoidal relationship between MLCK activation and Ca
2+
 concentration. 
The authors showed that increasing MLCK concentration increased the magnitude of 
force and decreased the time taken to achieve its half-maximal value while increasing 
MLCP concentration decreased the magnitude of force (Fajmut and Brumen, 2008). In 
addition to Ca
2+
 dependent activation of MLCK, a MLCP inactivation mechanism was 
included to explain the tonic force behavior of the airway smooth muscle. The 
progressive inactivation of MLCP in the model and slow deactivation of MLCK 
compared to its activation resulted in a Hill shaped force response for a given phasic 
calcium transient signal.  MLCP inhibition has been predominantly attributed to 
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agonist induced cell stimulation (Richards et al., 2002; Murthy, 2006). The model is 
hence useful to study the tonic contractile behavior and force enhancement due to 
MLCP inactivation, but has limited applicability to phasic contraction with relatively 
rapid contraction and relaxation cycles. 
 
Figure 2.19. Theoretical model of Fajmut et al. (2005a) for the interaction of Ca2+, 
CaM and MLCK (a) coupled to Hai and Murphy’s four state model (b) to model 
the calcium-contraction coupling in airway smooth muscle (Mbikou et al., 2006). 
 
The relationship between Ca
2+
 concentration, myosin phosphorylation and force varies 
significantly between tonic smooth muscle and phasic smooth muscle (Himpens et al., 
1988b; Gerthoffer et al., 1991; Zhao et al., 2008) due to differences in the expression 
level of contractile proteins and other cellular proteins (Szymanski et al., 1998; 
Mahavadi et al., 2008), activation properties of MLCK (Gerthoffer et al., 1991; Word 
et al., 1994), regulation of MLCP (Gong et al., 1992a), cross-bridge kinetics (Marston, 
1989; Hellstrand and Nordstrom, 1993; Murphy, 1994; Gregersen and Christensen, 
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2000; Murphy and Rembold, 2005) and secondary regulatory mechanisms (Krymsky 
et al., 2001; Lorenz et al., 2002; Choudhury et al., 2004).  Hence, models developed 
for tonic contractile behavior cannot be used directly to study phasic smooth muscle 
contraction which is the focus of this work.  
Table 2.1. Merits and limitations of the previous modelling studies on SM contraction. 





Description of the 
active and passive 
components of SM 
contraction 












between actin and 
myosin 










model for SM 
contraction 
a) The focus of the 
model is on agonist 
induced SM 
contraction. 
b) The model is not 
addressed towards a 
specific SM type. 
Mbikou et al.’s  
model (2006) 
Airway SM 
Detailed description of 
MLCK activation and 
extension of Hai and 
Murphy model with the 
Ca
2+
 dependence and 
MLCK kinetics 
Model for airway SM 






Extension of Hai and 
Murphy model with 
Ca
2+
 dependence for a 
phasic SM type 
Ca
2+
 dependent MLCK 
activity is described 
using a sigmoid 
function 




In summary, experimental studies have provided an understanding of the regulation of 
smooth muscle contraction at various levels. Electrophysiological studies have shown 
the regulation of GI motility by the electrical behaviour of the SMCs and the 
excitation-contraction coupling through the regulation of intracellular Ca
2+
 
concentration (Section 2.1).  Protein interaction and signalling studies have elucidated 
the reaction network involved in SM contraction (Section 2.2). Force measurements at 
cellular and tissue level have generated data on the contractile response of SM for an 
intracellular Ca
2+
 transient generated in response to an electrical stimulus (Section 
2.3). SM electrical models have been successful in describing the change in 
intracellular Ca
2+
 concentration as a function of change in SM membrane potential 
(Corrias and Buist, 2007).  In moving towards the target of a model for GI motility, 
the next step would be to develop a model to link electrical activity and mechanical 
activity of a SMC. Though generic models of SM contraction and models for other 
SM types (e.g., airway, vascular which are primarily tonic SM) have been developed 
(Section 2.4), a model specific for phasic gastric SM has not yet been developed. This 
study is hence aimed at developing a model for gastric smooth muscle and providing a 





3. Modelling Active Force Production in Gastric SMCs 
through Ca
2+
 dependent MLCK Activation. 
3.1. Introduction 
Calmodulin (CaM) is a 17 kDa Ca
2+
 binding protein involved in several intracellular 
Ca
2+
 dependent signalling pathways. Protein-protein interaction studies have shown 
that CaM has target binding sites for Ca
2+
 at two locations, one near the C-terminal 
and one near the N-terminal, with each site binding two Ca
2+
 ions (Persechini and 
Cronk, 1999). Thus, up to four Ca
2+
 ions could potentially bind to CaM in any order. 




)4CaM) undergoes a conformational change which 
enables it to bind target proteins and regulate their activity. Numerous intracellular 
proteins bind to (Ca
2+
)4CaM with high (Kd ≤ 10 nM), intermediate 
(10  nM  <  Kd  <  100  nM), and low (Kd  ≥ 100 nM) affinities (Persechini and Cronk, 
1999). The myosin light chain kinase (MLCK) enzyme is a high affinity target protein 
of CaM with the dissociation constant of approximately 1 nM (Kasturi et al., 1993; 
Johnson et al., 1996; Persechini and Stemmer, 2002; Geguchadze et al., 2004).  The 
local intracellular availability of CaM is of biological significance because different 
CaM binding proteins are regulated over a wide range of free CaM concentrations as 
well as by the amplitude and frequency modulation of intracellular calcium. Though 
high amounts of CaM are present in the cell, the involvement of CaM in numerous 
pathways results in limited levels of free cytosolic CaM (Persechini and Stemmer, 
2002). The relatively low levels of free CaM consequently limit the maximum 





Studies with the inhibitory agent wortmannin and knockout studies have shown that 
MLCK activation by (Ca
2+
)4CaM is the primary and necessary mechanism for the 
initiation of contraction in SMCs (Burke et al., 1996; He et al., 2008). MLCK has a 
catalytic core and a substrate binding site. MLCK, when bound to (Ca
2+
)4CaM, forms 
the active kinase complex which can phosphorylate the regulatory light chain (RLC) 
of the thick myosin filament. Phosphorylation of the myosin RLC results in a 
conformational change of the myosin heads and stimulation of actin-activated 
MgATPase resulting in cross-bridge cycling and active force production. Hence, when 




 ions bind to 
CaM to form the (Ca
2+
)4CaM  pool, which then goes on to activate MLCK. The 
activation of MLCK results in contraction of the SMC through myosin 
phosphorylation and its subsequent interaction with actin (Murthy, 2006). The active 
force produced is a function of the number of cross-bridges formed between actin and 
myosin (Gestrelius and Borgstrom, 1986; Hai and Murphy, 1988). A schematic 




Figure 3.1. Calcium-dependent mechanism of active contraction. MLCK is 
activated when bound to calmodulin carrying four Ca2+ ions. The activated 
MLCK enzyme triggers phosphorylation of 20 kDa light chain of the myosin 
filament which leads to formation of cross-bridges between myosin (M) and actin 
(A). The formation of cycling cross-bridges (AMp) results in shortening of the 
smooth muscle cell.  
A+ M     AMp 
4Ca
2+ 
+  CaM      (Ca2+)4 CaM  +   MLCK      (Ca
2+
)4 CaM-MLCK 




In this thesis, two approaches to describe MLCK activation have been explored. The 
first method, described in Section 3.2 was to develop a signal transduction pathway 
based description of MLCK activation following Figure 3.1. Inspired by experimental 
results depicting the activation of MLCK at various Ca
2+
 concentrations, the second 
approach described in Section 3.3 was to explain the Ca
2+
 dependence of MLCK 
activation through a direct mathematical function that would describe the 
experimentally observed relationship between MLCK activity and Ca
2+
.  
The mechanism of [Ca
2+
]i dependent active force production is described here in terms 
of two modules, the first describing the activation of MLCK through its interactions 
with calmodulin and Ca
2+
 ions, and the second consisting of a four state scheme 
describing myosin phosphorylation and cross-bridge formation between actin and 
myosin. 
 
3.2. MODULE I: MLCK activation by Ca2+ signalling pathway 
3.2.1. MLCK activation: preliminary model 
The formation of the (Ca
2+
)4CaM-MLCK complex through the binding of CaM to 
Ca
2+
 and MLCK leads us to several possible binding orders.  A theoretical model has 
been developed by Fajmut et al. (described in Section 2.4.7) with eight possible 
complexes through twelve reactions (Fajmut et al., 2005a).  However protein 
interaction studies and kinetic studies point toward six significant complexes in the 
pathway with other possible complexes being too transient to affect the pathway flux 
(Kasturi et al., 1993; Johnson et al., 1996). 
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Although the Lukas model is not specific to a type of SM, the reactions regulating 
contraction that are common across SM types have been described elaborately and the 
model provides a pathway framework for SM contraction that can be modified, 
refined and extended. Hence, the generic model for smooth muscle contraction 
developed by Lukas (Lukas, 2004) was used as the starting point for describing the 
MLCK activation. As mentioned in Section 3.1, up to four Ca
2+
 ions could potentially 
bind to CaM in any order. Insufficient experimental data is available to properly 
quantify the range of potential binding combinations and it was therefore assumed that 
Ca
2+
 ions bind to CaM in pairs, such that both of the sites at one terminal are occupied 
simultaneously. In addition, it was assumed that the binding was order independent, 
meaning that it was sufficient to model CaM as having two binding sites and not 
explicitly tracking which of the binding sites was occupied. Based on these 
assumptions, a pathway model was developed that contained nine reactions to 
describe the interaction between calcium, calmodulin and MLCK (Gajendiran and 
Buist, 2011). In the preliminary model, shown in Figure 3.2, zero, two or four Ca
2+
 








Figure 3.2. Signal transduction pathway for MLCK activation by intracellular 
Ca2+ ions through calmodulin. CaM = calmodulin; MLCK = myosin light chain 
kinase; Ca = Ca2+ ion; BP = buffering protein. Reactions are numbered and the 
corresponding details can be found in Table 3.1. 
 
A CaM buffering system was included following Lukas (Lukas, 2004b). Myosin Ic 
has been implicated in CaM buffering process where CaM bound to actomyosin 
filaments are released when Ca
2+
 concentration increases i.e. actomyosin filament gets 
unbound to CaM upon CaM binding to Ca
2+
 ions (Lukas, 2004b). Here CaM forms a 
complex with a buffering protein (BP) that sequesters CaM in the absence of free Ca
2+
. 
As the intracellular Ca
2+
 level increases, CaM is liberated from the BP as shown by 
the transitions marked as 8 and 9 in Figure 3.2. The scheme proposed by Lukas 
assumed that the binding of two Ca
2+
 ions dissociates CaM from a buffer complex and 
then (Ca
2+
)2CaM rapidly acquires two more Ca
2+
 ions before binding to and activating 
MLCK. Experiments have shown that both CaM and (Ca
2+
)2CaM can bind to MLCK, 
albeit without activating the enzyme (Johnson et al., 1996). MLCK is only activated 




)4CaM). The binding and 
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unbinding of MLCK to CaM and its Ca
2+
 bound complexes are depicted as vertical 
transitions in Figure 3.2.  The reactions involved in the pathway scheme shown in 
Figure 3.2 are given in Table 3.1. 
Table 3.1. Reactions involved in the activation of MLCK (Module I) by the interaction 
between CaM, Ca2+ and MLCK in the preliminary model .  
No. Reaction 
1 CaM + 2Ca
2+





 ↔  (Ca2+)4CaM 
3 CaM + MLCK ↔  CaM-MLCK 
4 (Ca
2+





)4CaM + MLCK ↔  (Ca
2+
)4CaM -MLCK 
6 CaM-MLCK + 2Ca
2+





 ↔  (Ca2+)4CaM –MLCK 
8 CaM + BP ↔  CaM-BP 
9 CaM-BP + 2Ca
2+
 ↔  (Ca2+)2CaM + BP 
 
In kinetic studies of biochemical reactions, the rate constants are commonly estimated 
by fitting to mass-action reaction kinetics and usually first order kinetics are assumed 
(Hartshorne, 1987). Hence, each of the reaction pathways shown in Figure 3.2 was 
assumed to exhibit mass action kinetics and the signal transduction system was 
described in terms of first order differential equations (ODEs) representing the fluxes 
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into and out of each state. This is best explained through an example using reaction 1 
from Table 3.1 and Figure 3.2 where two Ca
2+
 ions bind to one molecule of CaM.  
                       
(3.1) 
 
Given a forward reaction rate constant, kf, and a reverse reaction rate constant, kr, the 
rates of change of the reactants and product are given by  
 
 
         
  
             
              
      
  
  
     
  
  (3.2) 
 
Performing a similar analysis on each of these reactions yields a single ODE for each 
species. The ODEs were solved in MATLAB using the in-built ODE solver. To check 
convergence of the solution, the model was solved using two different ODE solvers, 
ode15s (a stiff solver) and ode45 (a non-stiff solver) and changing the tolerance values 
of the solvers. The solutions were invariant. 
 
3.2.2. MLCK activation: extended model 
After the initial studies, the binding of Ca
2+
 ions at the C-terminal and N-terminal 
binding sites of CaM was explicitly described. The difference in the binding 
properties between the N-terminal and C-terminal binding sites were subsequently 
included. The binding of calcium is slow and stronger (higher affinity) at the C-
terminus and rapid at its N-terminal site with lower affinity. C-terminus of CaM has 2-





 faster compared to the C-terminal and has faster dissociation rate 
compared to the C-terminus (Johnson et al., 1996).  The explicit description of the 
binding of calcium ions at the C-terminal and N-terminal binding sites subsequently 
led to the inclusion of cooperativity between the binding of Ca
2+
 ions and MLCK to 
CaM. Experiments studying Ca
2+ 
exchange with calmodulin in the presence of target 
proteins have shown that MLCK binding to CaM reduced the rate of Ca
2+
 dissociation 
from the N-terminal sites (a 140-225 fold decrease) and the C-terminal sites (a 6-24 
fold decrease) (Hartshorne, 1987, Kasturi et al., 1993). MLCK binding has also been 
shown to increase (by 9-fold) the C-terminal Ca
2+
 affinity. Thus CaM bound to 
MLCK binds to Ca
2+ 
rapidly at the C-terminus and more strongly at the C and N-
terminal sites compared to unbound free CaM. The explicit description of Ca
2+
 
binding at the C-terminal and N-terminal binding sites of CaM resulted in an extended 




Table 3.2. Reactions involved in the activation of MLCK (Module I) by the interaction 
between CaM, Ca2+ and MLCK in the extended model with the explicit description of Ca2+ 
binding at the C-terminal (indicated with subscript C) and N-terminal binding sites (indicated 
with subscript N) of CaM.  
No. Reaction 
1 CaM + 2Ca
2+
 ↔  (Ca2+)2CaMC 
2 CaM + 2Ca
2+










 ↔  (Ca2+)4CaM 
5 CaM + BP ↔  CaM-BP 
6 CaM-BP + 2Ca
2+
 ↔  (Ca2+)2CaMC + BP 
7 (Ca
2+





)2CaMC + MLCK ↔  (Ca
2+
)2CaMC -MLCK 
9 CaM + MLCK ↔  CaM-MLCK 
10 CaM-MLCK + 2Ca
2+
 ↔  (Ca2+)2CaMC -MLCK 
11 (Ca
2+
)2CaMC -MLCK + 2Ca
2+
 ↔  (Ca2+)4CaM -MLCK 
 
 
3.2.2. Module I: Parameter Estimation 





)4CaM in intact cells in the presence of two CaM-binding proteins. 
Stably transfected HEK-293 cells that express one of three CaM indicators with 
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varying affinities to CaM, FIP-CBSM-41 (Kd = 2 nM), FIP-CBSM-38(Kd = 45 nM) and 
FIP-CBSM-39 (Kd=400 nM) or only the Ca
2+
 indicator, FIP-CA37 (Kd = 0.6 µM) were 
produced (Persechini and Cronk, 1999). The CaM-binding sequences in the indicators 
were altered versions of the avian smooth muscle myosin light chain kinase sequence. 
FIP-CBSM-41 has a high affinity of Kd = 2 nm which is essentially the same as the 
affinity of MLCK to CaM with a Kd value of 1-2 nM (Persechini and Cronk, 1999; 
Persechini and Stemmer, 2002; Geguchadze et al., 2004). The free (Ca
2+
)4CaM 
concentrations produced in cells expressing each CaM indicator at different 
intracellular concentrations of free Ca
2+
 were calculated from the indicator emission 
ratios. The relationship between free (Ca
2+
)4CaM and free intracellular Ca
2+
 was 
shown to follow a sigmoid behavior. The experimental results shown in Figure 3.3 
were used to estimate the parameters of the Module I whose values were not available 
in the literature.  
The model can be visualized as a combination of two interdependent pathways. One 
consists of the reactions involved in the binding of four Ca
2+
 ions to CaM (reactions 1-
6 in Table 3.2) and the second consists of the interaction of the various species of the 
first pathway leading to target protein activation (reactions 7-11 in Table 3.2). The 
parameters of module I were estimated in two steps using the two different 






Figure 3.3. Free (Ca2+)4CaM concentrations in cells expressing FIP-CBSM-38() 
and FIP-CBSM-41() at different intracellular free Ca
2+ concentrations. The 
binding curves for the data are shown (Persechini and Cronk, 1999). 
 
3.2.2.1. Estimation of parameters pertaining to reactions involved in the binding 
of four Ca
2+
 ions to CaM (Reactions 1-6 in Table 3.2). 
 
First, the parameters involved in the formation of (Ca
2+
)4CaM through the interaction 
of Ca
2+
 and CaM were estimated by replacing the MLCK with a target protein (TP45) 
of affinity 45 nM. The reactions are shown in Table 3.3. The model was simulated to 
reach steady state at each Ca
2+
 concentration within a range of 0-100 µM and the 
steady state concentration of the species at each Ca
2+
 concentration was noted. The 
amount of free (Ca
2+





)4CaM data corresponding to FIP-CBSM-38. The result is shown 
in Figure 3.4 and the parameters are shown in Table 3.3.  
Most of the values for parameters shown in Table 3.3 were taken or derived from the 
literature. The rate constants of the respective reactions are indicated by the reaction 
number in the form of superscript. For few parameters (indicated by asterisk * in 
Table 3.3) the values were estimated by fitting to experimental data. Two methods 





), simulations were run with step increment of the parameter values 
from the lower bound to upper bound value of the range till the objective function met 
a specified tolerance value. The maximum of the absolute difference between the 
experimental free (Ca
2+
)4CaM concentration and the predicted free (Ca
2+
)4CaM 
concentration values from the model was used as the objective function and a 
tolerance value of 10
-3
 was specified. The apparent dissociation constant (Kd
7-9, 11
 in 
Table 3.3) of TP45 binding to various species of CaM was estimated by this method 
within a range of 0.04-0.06 µM (Pepke et al., 2010). The experimental data used for 
fitting represents the binding of target protein with a Kd value of 0.045 µM.   
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Table 3.3. Reactions with the binding of a target protein with Kd = 45 nM (TP45) and the 
respective forward (kf) and reverse (kr) reaction rates determined by parameter estimation. *- 
parameters estimated through fitting. #- the parameter calculated from the other two values. 
The rate constants of the respective reactions are indicated by the reaction number in the form 















1 CaM + 2Ca
2+
 ↔ (Ca2+)2CaMC 2.3 2.4 1.043 
(Johnson et 
al., 1996) 
2 CaM + 2Ca
2+





















Fajmut et al., 
2005; Pepke 
et al., 2010) 
5 CaM + BP ↔ CaM-BP 5 15 3 






 ↔  
(Ca
2+















60 2.4 0.04 










 (Pepke et al., 
2010) 




 0.051 fitted 
10 
CaM- TP45 + 2Ca
2+




44 0.49 0.011 













 4.1* 0.054 





The buffering scheme of CaM was adopted from the model developed by Lukas 
(Lukas, 2004b). However the apparent dissociation constant of the binding of the 
buffer protein (Kd
5
 in Table 3.3) and the binding of Ca
2+
 to the CaM-buffer protein 
complex (Kd
6
 in Table 3.3) were derived from Black et al.’ studies of the relationship 
between the CaM concentration available for binding of proteins and intracellular Ca
2+
 
concentration (Black et al., 2004). The forward reaction rate (kf
 6
) was estimated using 
the MATLAB built-in function ‘fminsearch’ which is an unconstrained nonlinear 
optimization procedure. The maximum of the absolute difference between the 
experimental data and the predicted values from the model was used as the objective 
function for estimating the parameters.  
 
 
Figure 3.4. Relationship between free intracellular Ca2+ and free (Ca2+)4CaM 
concentration. Simulated free (Ca2+)4CaM concentration (—) from the model 
fitted to experimental free (Ca2+)4CaM concentration (●) measured in the 
presence of binding protein (FIP-CBSM-38) shown in Figure 3.3. 
 



































(Persechini and Cronk, 1999) 
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After the fitting, the model was validated with a transient Ca
2+
 signal produced by a 
cell in response to an agonist as shown in Figure 3.5. FIP-CBSM-38 expressing cells, 
when treated with thyrotropin releasing hormone, produced reproducible intracellular 
free Ca
2+
 transients . The time course of free Ca
2+
 concentration and free (Ca
2+
)4CaM 
concentration after the addition of the agonist were determined in the FIP-CBSM-38 
expressing cells (Figure 3.5). The experimental Ca
2+
 curve was digitised using 
software called GetData. The transient Ca
2+
 concentration shown in Figure 3.5B was 
given as an input to the model and the time course of free (Ca
2+
)4CaM concentration 
obtained from the simulation were compared to the experimental free (Ca
2+
)4CaM 
concentration as shown in Figure 3.6. 
 
 
Figure 3.5. Changes in the free concentrations of Ca2+ and (Ca2+)4CaM produced 
in response to an agonist in cells expressing FIP-CBSM-38 (Kd = 45 nM). A) The 




)4CaM concentrations. B) Time 
courses for the free Ca2+ and (Ca2+)4CaM concentrations produced after the 
addition of agonist. Data from the traces in B were used to generate the 





Figure 3.6. Changes in the free (Ca2+)4CaM concentrations produced in response 
to transient change in intracellular free Ca2+. Both simulated and experimental 
free (Ca2+)4CaM have been normalized to their respective maximum values. A 
good correlation is observed between the simulation result and experimental data. 
 
A discrepancy in the relationship between free (Ca
2+
)4CaM and intracellular free Ca
2+
 
concentrations obtained from two different experimental setups (Figure 3.3 and Figure 
3.5A) was reported. It was noted that the maximum free (Ca
2+
)4CaM concentration 
(Figure 3.5A) obtained from the transient Ca
2+
 signal in response to agonist was 
noticeably less than the value determined in cells subjected to varying controlled free 
Ca
2+
 concentrations (Figure 3.3). To make a meaningful comparison, it was therefore 
necessary to normalise the free (Ca
2+
)4CaM concentrations from the model and the 
experiment to their respective maximum value. From Figure 3.6, it can be seen that 
there is good correlation between the experimental data and the simulation result. 
 






























































 - input signal










(Persechini and Cronk, 1999) 
69 
 
3.2.2.2. Estimation of the parameters pertaining to MLCK binding reactions 
(Reactions 7-11 in Table 3.2). 
 
After the estimation of parameters pertaining to reactions involved in the binding of 
four Ca
2+
 ions to CaM (Reactions 1-6 in Table 3.2), the next step was estimating the 
parameters pertaining to MLCK activation reactions (Reactions 7-11 in Table 3.2). 
For this, the experimental result from Persechini et al. corresponding to FIP-CBSM-41 
shown in Figure 3.3 was used.  FIP-CBSM-41, with the peptide sequence of MLCK, has 
the same affinity as MLCK (Persechini and Cronk, 1999).  This particular 
experimental data was chosen over other experimental results (Gallagher et al., 1991; 
Geguchadze et al., 2004) used by similar modelling studies (Fajmut et al., 2005) for 
the reason that the experiments were performed in an intact cell and the relationship 
has been shown in terms of absolute concentrations rather than MLCK  activities 
measured from in vitro enzyme assays.  
The model with MLCK binding reactions was simulated for different Ca
2+
 
concentrations in the range of 0-100 µM under steady state conditions and the amount 
of free (Ca
2+
)4CaM was compared and fitted to the experimental data of free 
(Ca
2+
)4CaM in the presence of high affinity target protein. The result is shown in 
Figure 3.7 and the parameters are shown in Table 3.4. The initial amount of free CaM 
and the binding indicator proteins were not reported for the experimental data. Here 
10 µM of total MLCK was used in the model and an initial free CaM concentration of 
2 µM was used (Persechini and Stemmer, 2002; Lukas, 2004b; Hong et al., 2009). It 
has been reported that in a cell the CaM-binding proteins outnumber CaM by a factor 
of approximately 2 on a molar basis and availability of free CaM is a limiting factor in 
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the activation of target proteins (Persechini and Cronk, 1999; Persechini and Stemmer, 
2002). The initial concentration of the species in Module I used for steady state 











)4CaM-MLCK were assumed to be zero. The 
concentration of CaM-MLCK was estimated by fitting. The steady state concentration 
of the species at the resting Ca
2+
 concentration (0.1 µM) was used as the initial 
condition for transient simulations and given in Appendix I. 
 
 
Figure 3.7. Relationship between free (Ca2+)4CaM and free Ca
2+ concentrations in 
the presence of MLCK, a high affinity CaM-binding protein. Simulated free 
(Ca2+)4CaM concentration ( —) from the model fitted to experimental free 











































Binding curve fit to the experimental data
(Persechini and Cronk, 1999) 
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Table 3.4. Reactions with the binding of a target protein with Kd = 2 nM (MLCK) and the 
respective forward (kf) and reverse (kr) reaction rates determined by parameter estimation in 
step two are shown in bold. The fitted parameters not shown in bold are the ones estimated in 
step one involving TP45. *- parameters estimated through fitting.
 #- the parameter calculated 









1 CaM + 2Ca
2+




2 CaM + 2Ca
2+





































































840 45.36 0.054 (Fajmut et 
al., 2005) 




































The values of the parameters indicated by asterisk (*) in Table 3.4 were estimated as 











 (Torok et al., 1998). The 
maximum of the absolute difference between the experimental free (Ca
2+
)4CaM 
concentration in the presence of target protein, FIP-CBSM-41 (Kd = 2 nM) and the 
predicted free (Ca
2+)
4CaM concentration values from the model in the presence of 





Table 3.5. Initial concentration of the species in Module I used for steady state simulations. 
The steady state concentration of the species at the resting Ca2+ concentration (0.1 µM) was 






(Persechini and Cronk, 1999; 





(Johnson et al., 1996) 
CaM-BP 2.885 (Lukas, 2004)b 
BP 15.0 (Lukas, 2004)b 
MLCK 9.385 (Lukas, 2004)b 
CaM-MLCK 0.615 fitted 
 
The results (Figure 3.7) from the model show a biphasic behavior with an initial 
increase and then a decrease after reaching the maximum value (2.8 nM) under CaM 
limiting conditions (i.e. for a total [CaM] of 5.5 µM with initial free CaM 
concentration of 2 µM).  With 10 µM of total CaM and 10 µM of total MLCK, the 
biphasic behavior was still observed. However, there was an almost 6 times increase 
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in the maximum free (Ca
2+
)4CaM concentration (16.6 nM). With a total CaM 
concentration of 11 µM, greater than the 10 µM initial MLCK concentration, free 
(Ca
2+
)4CaM showed a sigmoid relationship with the Ca
2+
 concentration. Under these 
conditions, CaM is in excess compared to the amount of its target protein and thus 
does not limit target protein activation.  
Since the model includes only the activation of one CaM target protein, unlike an 
intact cell with numerous CaM binding proteins, a limited concentration of initial free 
CaM (2 µM) that would be entirely available for MLCK binding and activation was 
used in the model (Persechini and Stemmer, 2002).  Hence in the model, due to high 
affinity and cooperative binding, the free (Ca
2+
)4CaM produced from the limited total 
CaM is rapidly converted to (Ca
2+
)4CaM-MLCK and causes the decrease in the 
concentration of free (Ca
2+
)4CaM as seen in Figure 3.7. 
 
3.2.3. Calmodulin is a limiting factor in the cell. 
It has been shown that CaM plays more significant role in signal transduction and 
regulation of its numerous target proteins than just being a passive relay channel for 
intracellular Ca
2+
 (Persechini and Stemmer, 2002). In particular, the limited pool of 
CaM within the cell impacts the signalling of the target proteins and also enables 
cross-talk between CaM dependent signalling pathways. The effect of the limited 






Table 3.6. Effect of concentration of free [CaM] on MLCK activation. The first row shows a 
CaM limiting condition where [CaM]total is less than the [MLCK]total. The second shows a 




Percentage of total 
MLCK activated 
5.5 60 % 
11 100 % 
 
 
With a limiting total CaM concentration of 5.5 µM, even at high Ca
2+
 concentrations, 
the level of MLCK activation is limited to 60% of its theoretical maximum. Increasing 
the concentration of total CaM (11 µM) in excess to total MLCK (10 µM) sees full 
activation of MLCK in a high Ca
2+
 environment. Thus, it is evident that MLCK 







Figure 3.8 Effect of CaM concentration on MLCK activation. Percentage of 
MLCK activation has been shown for two concentrations of total CaM - total 
CaM of 5.5 µM with initial free CaM of 2 µM (solid line) and total CaM of 11 
µM (dashed line). 
 
 
3.2.4. Cooperativity between binding sites of calmodulin 
As mentioned in Section 3.2.1, the interaction between Ca
2+
, CaM and MLCK was 
first modelled with a compact description with nine reactions (Table 3.1). The binding 
of calcium ions at the C-terminal and N-terminal binding sites were not described 
explicitly. With this description, free (Ca
2+
)4CaM behavior did not show good 
agreement with the experimental result as shown in Figure 3.9. The results from this 
description also showed minimal and slow activation of MLCK at Ca
2+
 concentrations 
between 0.1-0.4 µM as shown in  Figure 3.10 and did not fit well to the trend shown 
by experimental results (Figure 3.3). Though MLCK activation reached the same 
steady state maximum in the preliminary nine reaction model and the extended eleven 




































Total [CaM] less than total [MLCK]
Total [CaM] greater than total [MLCK]
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reaction model, the rate of activation was higher in the eleven reaction model as seen 
in Figure 3.10.  
The reactions and their parameter values shown in Table 3.4 have been extracted and 
shown in smaller tables (Table 3.7, Table 3.8, Table 3.9, and Table 3.10) to explain 
the cooperativity between binding sites of CaM. Table 3.7 and Table 3.8 show the 
cooperativity between Ca
2+
 binding sites of CaM and Table 3.9 and Table 3.10 show 
the cooperativity between Ca
2+ 
binding and MLCK binding to CaM. 
 
 
Figure 3.9. Relationship between free (Ca2+)4CaM concentration and Ca
2+ from 
the extended model (solid line) with the explicit description of Ca2+ binding at C-
terminal and N-terminal of CaM and the preliminary model (dashed line) without 
the explicit description of Ca2+ binding at C-terminal and N-terminal of CaM. 
The extended model showed good agreement with the experimental result 
compared to the preliminary model. The cooperativity between the binding sites 
of CaM leads to higher levels of (Ca2+)4CaM formation. However the increase in 
(Ca
2+
)4CaM levels lead to increased (Ca
2+
)4CaM-MLCK formation causing a 
biphasic behavior. Cooperativity in binding to MLCK as explained in Table 3.9 
leads to greater conversion of (Ca2+)4CaM to (Ca
2+)4CaM-MLCK, hence giving 
lower levels of (Ca2+)4CaM in the extended model. 









































Figure 3.10. Relationship between MLCK activation and Ca2+ with (eleven 
reaction model - solid line) and without (nine reaction model - dashed line) the 
explicit description of Ca2+ binding at C-terminal and N-terminal of CaM. The 
cooperativity between the binding sites of CaM leads to faster activation of 
MLCK at the optimal Ca2+ range. 
 
The difference in the binding properties of the two Ca
2+
 binding sites of CaM has been 
incorporated in the model as shown in Table 3.7.  
 
Table 3.7. Difference in the binding properties of the two Ca2+ binding sites of CaM. In the 
model, the N-terminal of CaM binds Ca2+ 70 times faster and has 208 fold faster dissociation 
rate compared to the C-terminal.  The 3 times higher Kd value for N-terminal binding shows 














1 CaM + 2Ca
2+
 ↔ (Ca2+)2CaMC 2.3 2.4 1.0435 
2 CaM + 2Ca
2+
 ↔ (Ca2+)2CaMN 160 500 3.125 

















































  With explicit description of
  Ca
2+
 binding at C-terminal &
  N-terminal of CaM
  Without explicit description of
  Ca
2+
 binding at C-terminal &
  N-terminal of CaM
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In addition to the difference in the binding properties, cooperativity between the two 
calcium binding sites of CaM has been observed and shown in Table 3.8 (Johnson et 
al., 1996; Kasturi et al., 1993). CaM with Ca
2+
 bound at its N-terminal acquires two 
Ca
2+
 ions at its C-terminal with more affinity and binding of Ca
2+
 at the C-terminal 
reduces the dissociation rate of Ca
2+
 from the N-terminal.  In the model, CaM bound 
with Ca
2+ 
at its N-terminal binds to Ca
2+
 at its C-terminal 1.2 times faster compared to 




) in Table 3.8. CaM 
bound with Ca
2+ 
at its C-terminal binds to Ca
2+
 at its N-terminal with 1.2 times more 
affinity compared to free CaM as reflected by Kd values of reaction 2 and 4 in Table 
3.8. Thus cooperativity between the two calcium binding sites lead to elevated levels 
of free (Ca
2+
)4CaM at high Ca
2+
 concentrations. Elevation of free (Ca
2+
)4CaM levels 




Table 3.8. Cooperativity between the two calcium binding sites of CaM. In the model, CaM 
bound with Ca2+ at its N-terminal binds to Ca2+ at its C-terminal 1.2 times faster compared to 
free CaM as reflected by Kf values of reaction 1 and 3. CaM bound with Ca
2+ at its C-terminal 
binds to Ca2+ at its N-terminal with 1.2 times more affinity compared to free CaM as reflected 














1 CaM + 2Ca
2+
 ↔ (Ca2+)2CaMC 2.3 2.4 1.0435 
2 CaM + 2Ca
2+














In addition to the cooperativity between Ca
2+
 binding sites of CaM, MLCK binding to 
CaM has also been shown to affect the Ca
2+
 binding dynamics of calmodulin (Kasturi 
et al., 1993; Johnson et al., 1996).  Calmodulin has been shown to be present both in 
free form and in complex with target proteins (Hong et al., 2009). Apart from the 
calcium dependent binding of CaM to MLCK, CaM-MLCK complexes associated 
with acto-myosin filament structures have been isolated (Hong et al., 2009). MLCK 
binding to CaM has been found to increase the Ca
2+
 affinity at the N-terminal of CaM. 
The dissociation rates of Ca
2+
 from the C-terminal and N-terminal binding sites of 
CaM have also been shown to reduce in the presence of MLCK (Kasturi et al., 1993; 
Johnson et al., 1996).  The effect of MLCK binding on the Ca
2+ 
binding kinetics of 
CaM is shown in Table 3.9. In the model, MLCK binding to CaM decreases the 
dissociation rate (kr) of Ca
2+






(reactions 1 and 10 in Table 3.9) as reported by Johnson et al. (1996) and Kasturi et al. 
(1993) and increases the the Ca
2+
 affinity at the N-terminal of CaM by 11 times as 
reflected by the Kd values in reactions 4 and 11. This results in the endogenous CaM-
MLCK complex of the acto-myosin structure and resting CaM-MLCK pool acquiring 
calcium rapidly when intracellular calcium level rises.  At a resting Ca
2+
 concentration 





Table 3.9. Effect of MLCK binding on the Ca2+ binding kinetics of CaM. In the model, MLCK 
binding to CaM decreases the dissociation rate (Kr) of Ca







as seen in reactions 1 and 10 and increases the the Ca2+ affinity at 














1 CaM + 2Ca
2+
 ↔ (Ca2+)2CaMC 2.3 2.4 1.0435 
10 CaM-MLCK + 2Ca
2+
















160   36.8 0.23 
 
 
Figure 3.11. Concentration of CaM-MLCK complex. CaM-MLCK complexes 
associated with acto-myosin filament structures and calcium dependent binding 
of CaM to MLCK resulted in a CaM-MLCK concentration of 19.5% of total 
CaM at resting Ca2+ concentration (0.15µM).  

































CaM bound to Ca
2+
 at its C-terminal site also acquires MLCK with increased affinity 
compared to free CaM. CaM bound to four Ca
2+ 
ions binds to MLCK with the highest 
affinity of 1 nM. This is shown in Table 3.10. 
 
Table 3.10. CaM bound to Ca2+ ions binds to MLCK rapidly and with more affinity.  In the 
model, CaM bound to Ca2+ at its C-terminal site acquires MLCK rapidly and with increased 
affinity compared to free CaM as could be seen in reactions 10 and 11. (Ca2+)4CaM binds to 























840 45.36 0.054 
7 (Ca
2+
)4CaM + MLCK ↔ (Ca
2+
)4CaM-MLCK 201.81 0.222 0.0011 
 
During a rapid Ca
2+
 transient (half-width 0.6 ms) as shown in Figure 3.12 and in the 
absence of a target protein, it was observed that 70% of N-terminal and 20% of the C-
terminal to be occupied with Ca
2+ 
(Johnson et al., 1996). Binding of four Ca
2+
 ions at 
the calcium binding sites has been found to cause a change in the conformation of the 
CaM molecule exposing the protein binding site thus enabling the binding of the 
target protein to the Ca
2+
-CaM complex. Thus, it can be understood that when there is 
rapid increase and decrease in intracellular calcium, the N-terminal binding site acts as 
a sensor by responding rapidly to the Ca
2+
 flux and causing opening or closing of the 





Figure 3.12. Time course of a Ca2+ transient (∆) and the time course of the 
occupancy of the CaM N-terminal () and C-terminal () Ca2+ binding sites in 
response to the Ca2+ transient were simulated by Johnson et al.(Johnson et al., 
1996). In the absence of a target protein, it was observed that 70% of N-terminal 
and 20% of the C-terminal to be occupied with Ca2+. 
 
The formation of (Ca
2+
)2CaM complexes and (Ca
2+
)2CaMC-MLCK complexes is 
shown in Figure 3.13. Due to cooperativity in binding shown in Table 3.7 and Table 
3.10, CaM bound to Ca
2+
 at its C-terminal site ((Ca
2+
)2CaMC) binds to two more Ca
2+
 
at its N-terminal site with more affinity to form (Ca
2+
)4CaM or binds to MLCK to 
form (Ca
2+
)2CaMC-MLCK. Hence the concentration of (Ca
2+
)2CaMC is lower 
compared to (Ca
2+
)2CaMN as seen in Figure 3.13. Owing to strong affinity and low 
dissociation rate of calcium at the C-terminal binding site, it has been suggested that at 
resting calcium levels in cells, 50-80% of CaM’s C-terminal may be bound to calcium 
(Johnson et al., 1996). Our model showed 37.5% occupancy at the C-terminal at the 
resting Ca
2+ 
level ([Carest] = 0.15µM). The value suggested by Johnson et al. (1996) 
may be higher because, the C-terminal Ca
2+
 dissociation rate (0.07 s
-1
) of the peptide 
complex, RS-20, used to study Ca
2+
 occupancy of CaM was 6 times lower than the C-
terminal Ca
2+
 dissociation rate of MLCK (0.39 s
-1
). As shown in Figure 3.13, 26% of 
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total [CaM] are converted to (Ca
2+
)2CaMC-MLCK complexes by two reactions, (i) 
(Ca
2+
)2CaMC, binding to MLCK rapidly and with stronger affinity compared to free 
CaM and (ii) CaM-MLCK acquiring two Ca
2+
 ions at its C-terminal site with 
increased affinity compared to free CaM. After reaching a peak, (Ca
2+
)2CaMC-MLCK 
concentration decreases due to its conversion to (Ca
2+






Figure 3.13. Formation of (Ca2+)2CaM and (Ca
2+)2CaMC-MLCK complexes. 
Calcium binding to the C-terminal with strong affinity but at a slower rate is 
shown by the solid line. (Ca2+)2CaMC is rapidly converted to either (Ca
2+)4CaM  
and (Ca2+)2CaMC-MLCK. Calcium binds to the N-terminal rapidly but with a 
lower affinity and is shown by dashed line. (Ca2+)2CaMC-MLCK complexes 
shown by dotted lines are formed by two reactions –(i) CaM bound to calcium at 
its C-terminal site, binds to MLCK rapidly and with stronger affinity compared 
to free CaM to form (Ca2+)2CaMC-MLCK complex and (ii) CaM bound to 
MLCK acquires two Ca2+ ions at its C-terminal site with increased affinity 
compared to free CaM by reducing the rate of dissociation and lead to formation 
of (Ca2+)2CaMC-MLCK complex. 
 
Calmodulin bound to MLCK and calcium at the C-terminal binding site i.e. 
(Ca
2+
)2CaMC-MLCK at resting Ca
2+
 levels would rapidly acquire two Ca
2+
 ions at the 
























































































N-terminal site when there is an increase in intracellular Ca
2+
, thus leading to the rapid 
activation of MLCK and hence initiation of contraction. This is shown in Figure 3.14 
where the inclusion of the cooperativity leads to rapid and increased activation of 
MLCK compared to the preliminary model. CaM bound to MLCK reduces the rate of 
dissociation of Ca
2+
 from the binding sites on CaM and this allows a rapid Ca
2+
 
transient to result in formation of a stable active enzyme pool to facilitate the 





 dissociates from the N-terminal faster due to 
greater dissociation constant compared to C-terminal and leads to inactivation of 
MLCK. Since four Ca
2+
 ions are required for the active enzyme complex, dissociation 
of Ca
2+
 from the N-terminal site is sufficient to cause inactivation. Since the 
dissociation of Ca
2+
 from the C-terminal binding site is too slow, the rate of 
dissociation of Ca
2+






Figure 3.14. Formation of MLCKactive i.e., (Ca
2+)4CaM-MLCK complex in the 
extended model (solid line) and the preliminary model (dashed line). It can be 
seen that the formation of (Ca2+)4CaM-MLCK is rapid in the extended model 
with the explicit description of Ca2+ binding at C-terminal and N-terminal of 
CaM. 
 
3.2.5. Transient MLCK activation 
Figure 3.14 shows MLCK activation for a wide Ca
2+ 
range of 0.01-100 µM under 
steady state conditions. Under physiological conditions, a typical range of 0.1-1.0 µM 
of [Ca
2+
]i has been observed (Kim et al., 1997; McCarron et al., 2006) and MLCK is 
activated transiently with respect to changes in [Ca
2+
]i. A transient signal with Ca
2+
 
concentrations in the range of 0.2 – 1.2 µM showed corresponding activation of 
MLCK with a steep relationship with Ca
2+
 in the range of 0.4 µM to 0.8 µM as seen in 
Figure 3.15. 
 



































  Extended model
  Preliminary model
86 
 
       
        
 
Figure 3.15. A) Transient Ca2+ signal of concentrations 0.2 µM 0.4 µM, 0.6 µM, 
0.8 µM, 1 µM and 1.2 µM. B) MLCK activation corresponding to the Ca2+ signal 
shown in (A).  A 50% increase in the Ca2+ concentration from 0.4 µM to 0.6 µM 
resulted in an increase of 140% in MLCK activation. However a 50% increase in 
the Ca2+ concentration from 0.8 µM to 1.2 µM resulted in an increase of only 37% 
in MLCK activation. This reflects the steep relationship between MLCK 
activation and Ca2+ in the Ca2+ range of 0.4 µM to 0.8 µM as seen in Figure 3.14. 
C) Increase in Ca2+ concentration above 0.4 µM decreased the time taken for 
half-maximal (t1/2) activation of MLCK. t1/2 for 0.2, 0.4, 0.6, 0.8, 1.0, and 1.2 µM 
of Ca2+ are 2, 2.02, 1.99, 1.97, 1.96, and 1.96 s respectively. 
 
 A 50% increase in the Ca
2+
 concentration from 0.4 µM to 0.6 µM resulted in an 
increase of 140% in MLCK activation. However a 50% increase in the Ca
2+
 
concentration from 0.8 µM to 1.2 µM resulted in an increase of only 37% in MLCK 

































































 range of 0.4 µM to 0.8 µM  as seen in both transient condition (Figure 3.15) 
and steady state condition (Figure 3.14). In addition to Ca
2+
 dependent change in 
amplitude of the MLCK activation, simulation under transient conditions (Figure 3.15) 
showed that increase in Ca
2+ 
concentration increased the rate of activation of MLCK. 
As shown in Figure 3.15, increase in Ca
2+
 concentration decreased the time taken for 
half-maximal activation of MLCK with a significant decrease in the Ca
2+
 range of 0.4 
µM to 0.8 µM. Hence, when the intracellular [Ca
2+
]i increases above the threshold 
concentration, MLCK activation is triggered and contraction in initiated. The 
relationship between [Ca
2+
]i and MLCK activation can be attributed to the active force 
behavior in SMCs. Experiments have shown that force development exhibited 
maximal sensitivity to [Ca
2+
]i between 0.15 µM and 0.5 µM and also physiological 
stimuli increasing Ca
2+
 to a maximum of 0.6 µM - 0.8 µM produce full contraction 
(Yagi et al., 1988).  
 
3.3. MODULE II: Active force generation 
The first component of the model, Module I predicted the Ca
2+
 dependent MLCK 
activation. The relationship between MLCK activation and cross-bridge formation 
between actin and myosin is explained in Module II. Module II, shown in  Figure 3.16, 
describes the active force generation in SMCs and has been developed based on Hai 
and Murphy’s four state model described in Section 2.4.4 (Hai and Murphy, 1988). 
The activated form of MLCK (MLCKactive or (Ca
2+
)4CaM-MLCK) upregulates the 
availability of actin binding sites on the myosin light chains, allowing cross-bridge 
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formation and active force generation (Murthy, 2006). Here the concentration of 
MLCKactive is calculated in Module I and is the key input to Module II. A second 
enzyme, myosin light chain phosphatase (MLCP), dephosphorylates the regulatory 
myosin light chain and the resulting conformational change inhibits cross-bridge 
formation. The level of cross-bridge formation thus depends on the balance between 
the activities of MLCKactive and MLCP.  
 
 
Figure 3.16. Extended Hai and Murphy model. A = actin; M = myosin; Mp = 
phosphorylated myosin; MLCKactive = activated myosin light chain kinase; MLCP 
= myosin light chain phosphatase; ATP = adenosine-5'-triphosphate; K1-7 = 
reaction rate constants. The corresponding details can be found in Table 3.11. 
 
The cross-bridge attachment rate (K3), detachment rate (K4) and latch bridge 
detachment rate (K7) influence the total number of cross-bridges and are shown as 
vertical transitions in Figure 3.16. The Ca
2+
 sensitive control mechanisms regulate the 
horizontal transitions in Figure 3.16, moving from a passive state (either decoupled or 
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in a latch bridge) to an active state in which cross-bridge cycling occurs upon an 
increase in intracellular Ca
2+
. The resulting four reactions are given in Table 3.11.  
Table 3.11. Reactions involved in active force generation via cross bridge cycling, as 
described by Equations 3.3-3.6. 
No. Reaction 
1 A + M ↔ A + Mp 
2 A + Mp ↔ AMp 
3 AMp ↔AM 
4 AM → A + M 
 
Using the enzyme kinetics data of MLCK from Hong et al. (2009), phosphorylation of 
regulatory MLC by MLCKactive was modelled based on Henri-Michaelis-Menten 
enzyme kinetics whereby the flux is directly dependent on the enzyme concentration 
as shown in Equation 3.3 (Bowden, c2004). Thus, the rate of myosin phosphorylation 
is a function of the concentration of MLCKactive available at any given time. This 
control mechanism provides the link between the intracellular Ca
2+
 concentration and 
cross-bridge cycling and was used to extend the four state model of cross-bridge 
cycling (Hai and Murphy, 1988). The rate constants K1, K2, K5 and K6 controlling the 
phosphorylation and dephosphorylation of myosin in the original Hai and Murphy 
model have been replaced by Henri-Michaelis-Menten kinetics as shown in Equations 
3.3 - 3.6. The evolution of the four species (M, Mp, AMp and AM) shown in Figure 
3.16 with time is described by Equations 3.3 - 3.6. It was assumed that actin is present 
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in abundance and its concentration does not affect the cross-bridge dynamics. The 
concentration of MLCKactive in Equations 3.3 - 3.6 is received from Module I. 
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The sum of the concentration of the four species (M, Mp, AMp, and AM) at any point 
of time will be equal to the total myosin concentration ([M]total) and this was verified 
in the model solutions. In order to extract physically meaningful output from the 
model, the values of [Mp], [AMp] and [AM] were used to calculate the percentage of 
myosin phosphorylation and number of cross-bridges formed in a SMC as specified in 





                        
          
        
 (3.7) 
 
where [M]total is the total myosin concentration. Upon myosin phosphorylation, active 
force is generated through the formation of cross-bridges (AMp) and latch-bridges 
(AM). 
 
               (3.8) 
 
The concentration of cross bridges (n) are normalized to their maximum value (nmax) 
as given in Equation 3.9. The maximum number of cross bridges was set to 80% of 
total myosin (Hai and Murphy, 1988). 
 
    
 
    
 (3.9) 
 
Previous studies have suggested that active force, F can be considered to be 
proportional to the number of cross-bridges and latch-bridges (Gestrelius and 
Borgstrom, 1986). Based on this premise, the fraction of attached cross- and latch-
bridges, N, was used to estimate the resultant force, 
 




where Fmax is the maximum achievable force. For N, a value of zero indicates the 
absence of any cross- or latch-bridges, and a value of one indicates the production of a 
maximal force where 80% of total myosin heads are bound to actin. 
 
3.3.1. Module II: Parameter Estimation  
To parameterize Module II, the model was simulated with transient calcium data 
obtained from gastric smooth muscle cells and the force values from the same 
experiment as shown in Figure 3.17. Ozaki et al. (1991a) measured the Ca
2+
 transients 
and spontaneous contractions in canine antral circular smooth muscle strip.  
 
Figure 3.17. Spontaneous contractions and Ca2+ transients measured in antral 
circular smooth muscle by Ozaki et al. Data in the traces have been normalized 




However, the experimental work reported calcium transients in terms of flourescence 
ratio (F340/F380) and did not give calibration details. Hence it was necessary to estimate 
the calcium concentrations corresponding to the ratio values reported. To overcome 
this, calcium concentration values corresponding to spontaneous slow waves with a 
plateau membrane potential of -40 mV were obtained from an electrophysiology 
model developed by Corrias and Buist (2007).  The experimental curve for calcium 
was digitised with a resting Ca
2+
 concentration of 0.1 µM and a peak Ca
2+
 
concentration of 0.326 µM (Kim et al., 1997; McCarron et al., 2006, Corrias and 
Buist, 2007). The model was simulated with the digitised Ca
2+
 time course, as an input 
as shown in Figure 3.18. The values of K3, K7 and MLCP concentration were 
estimated by fitting to experimental data from canine antral smooth muscle (Ozaki et 
al., 1991a). As mentioned in Section 3.3, normalized force (N) was calculated as the 
total number of cross bridges normalized to their maximum value (80% of total 
myosin). The absolute difference between the experimental normalized force values 
and the predicted normalized force values from the model was used as the objective 
function for estimating the parameters (K3, K7 and MLCP). A mean square error of 
1.957e-06 between the model normalized force and experimental normalized force 
was obtained. 
A total myosin concentration of 45 µM was used in the model (Hong et al., 2009). 
The steady state values of the various species of the module II at the resting Ca
2+
 
concentration (0.1 µM) are listed in Table 3.13. 
The experimental force values were also normalized to the maximum value of N, to 
facilitate the comparison between model results and experimental values and fitting of 
the model. The fitting of normalized force from the model to the experimental force 
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values is shown in Figure 3.18 and the parameters are shown in Table 3.12. The model 
showed a good fit to the experimental force behavior in the upstroke phase. However 
the relaxation phase produced by the model was slower than the experimental result.  
 
 
Figure 3.18. Fitting of the normalized force from the model to the experimental 
normalized force from Ozaki et al. (1991a). The corresponding input Ca2+ data is 
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  Experimental normalized force















(Ozaki et al., 1991) 
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Table 3.12. Parameters involved in active force generation via cross bridge cycling, as 
described by Equations (3.3) - (3.6), and their respective values. Vmax (= kcat. [E]) is 
the maximum reaction rate of enzyme E and Km is the substrate concentration at 
which a half-maximal reaction rate is achieved.  




(Persechini and Hartshorne, 1983; 
Ikebe and Reardon, 1990; Lukas, 
2004b; Hong et al., 2009) 
Km_MLCKactive 10 µM 
(Persechini and Hartshorne, 1983; 
Ikebe and Reardon, 1990; Lukas, 




K4 K3/4 (Hai and Murphy, 1988) 
kcat _MLCP 30 s
-1
 
(Ichikawa et al., 1996; Feng et al., 
1999) 
Km_MLCP 14.3 µM 





[MLCP] 7.703 µM fitted 
 
 
Table 3.13. Steady state values of the various species of the module II at the resting Ca2+ 











3.4. Calcium, myosin phosphorylation and cross-bridge formation 
The objective of the modelling work here is to study the relationship between the 
intracellular calcium concentration and active force production. Active force 
production in a smooth muscle cell is induced by phosphorylation of myosin by 
MLCKactive and subsequent cross-bridge formation between actin and myosin. Myosin 
phosphorylation (Equation 3.7) was calculated at each Ca
2+ 
concentration in the range 
0.01-100 µM, under steady state conditions and is shown in Figure 3.19. A limiting 
free CaM concentration of 2 µM giving 60% of maximum MLCK activation resulted 
in a maximum of 61% of myosin phosphorylation with a constant MLCP 
concentration of 7.7µM. Ozaki et.al (1991a) showed a maximum of 0.3 mol Pi/mol 
light chain of myosin phosphorylation in smooth muscle exhibiting acetylcholine 
stimulated contractions which showed peak force five times higher than the peak of 
spontaneous contractions. Maximum contraction of SMCs have been observed at Ca
2+
 
concentrations around 0.6 - 0.8 µM (Yagi et al., 1988). At 0.8 µM of Ca2+, 30% of 
myosin phosphorylation was predicted by the model. This is in close agreement with 






Figure 3.19. Relationship between myosin phosphorylation and intracellular free 
[Ca2+]i under steady state conditions. With a constant MLCP concentration, 
myosin phosphorylation also shows a sigmoid relationship with [Ca2+]i. The two 
points (■) show the steady state myosin phosphorylation levels corresponding to 
the [Ca2+]max values (0.4 µM and 0.6 µM) used for transient simulation in Figure 
3.22. 
 
3.4.1 Input Calcium Signal 
After the steady state analysis, the model was simulated under transient conditions. A 
prescribed intracellular [Ca
2+
]i transient, such as the one that accompanies membrane 
depolarization during a slow wave, was used as the input signal to the model to 
simulate the phasic contractions. Ca
2+
 transient function (Equation 3.11) was adapted 
from Mbikou et al. (2006) and the dynamics were modified to represent the [Ca
2+
]i 
cycling typically observed in GI SMC by fitting t1,t2 ,t3 and Ca
2+
 decay constant, k 
(Kim et al., 1997; Corrias and Buist, 2007). The intracellular Ca
2+
 concentration rises 
from a resting value, [Ca
2+
]r at time t1 to reach a maximum value, [Ca
2+
]max at time, t2  
before returning to [Ca
2+
]r at time t3. 






















































                                                                                                          
             
          
     
    
     
                        
             
          
      








]max were derived from the intracellular calcium 
recordings from Kim et al. (1997) and McCarron et al. (2006). One such experimental 
[Ca
2+
]i transient is shown in Figure 3.20 from Kim et al. (1997). Kim et al. (1997) 
reported Ca
2+
 peak values from 350 nM to 800 nM under various experimental 
conditions. Calcium recovery to its resting level (100 nM) was reported to be 
completed within 15-20 seconds. Vogalis et al. (1991) reported that on repolarization, 
intracellular [Ca
2+
]i decreased slowly with a time constant of 2-3 seconds and the rate 
depended on the magnitude of intracellular [Ca
2+
]i. Based on these experimental 
observations, for a calcium wave of three cycles per minute (Corrias and Buist, 2007), 
the estimated values of t1, t2 and t3 for the first cycle are 0 s, 2 s and 20 s, respectively. 
A Ca
2+
 decay constant, k, equal to 0.4 s
-1
 was used. A typical calcium transient 
generated by Equation 3.11 is shown in Figure 3.20B for a [Ca
2+











Parameter Value Ref 
[Ca
2+
]r 0.1 µM 
(Vogalis et al., 1991; Kim et al., 
1997; McCarron et al., 2006; 
Corrias and Buist, 2007) 
[Ca
2+
]max 0.6 µM 
(Vogalis et al., 1991; Kim et al., 
1997; McCarron et al., 2006) 
t1 0 s 
(Vogalis et al., 1991; Kim et al., 
1997; McCarron et al., 2006; 
Corrias and Buist, 2007) 
t2 2 s 
(Vogalis et al., 1991; Kim et al., 
1997; McCarron et al., 2006; 
Corrias and Buist, 2007) 
t3 20 s 
(Vogalis et al., 1991; Kim et al., 
1997; McCarron et al., 2006; 
Corrias and Buist, 2007) 
K 0.4 s
-1 (Vogalis et al., 1991; Kim et al., 
1997; McCarron et al., 2006) 
 
 
                                                                                   
Figure 3.20.  A) Ca2+ transients observed in guinea pig gastric myocytes under 
various experimentally evoked depolarizations (Kim et al., 1997). In cells held 
under voltage clamp at -80 mV, the resting [Ca2+]i was 102 ± 6.3 nM. Upon 
repolarization to -80 mV, [Ca
2+
]i slowly recovered to its resting level. Recovery 
was completed within 15-20 seconds. B) [Ca2+]i transient produced by Equation 


























3.4.2 Simulation of Myosin Phosphorylation 
Calcium transients with two different peak values, as shown in Figure 3.21, were used 
to study the relationship between Ca
2+
 and myosin phosphorylation. In the 
physiological situation, the intracellular Ca
2+
 concentration that is reached during a 
phasic activation is modulated by neurotransmitters and other agonists. Here, the 
[Ca
2+
]max variable in the Ca
2+
 input signal was used to represent different levels of 
cellular excitation (Kim et al., 1997; McCarron et al., 2006). 
From Figure 3.21 and Figure 3.22, it can be seen that, as expected, an increase in the 
magnitude of the Ca
2+
 concentration results in increased myosin phosphorylation 
levels in the cell due to elevated levels of MLCKactive. Increasing Camax by 50% 
resulted in a 203.4% increase in the peak levels of myosin phosphorylation. This can 
be explained in part by considering Figure 3.14 and Figure 3.15 where it can be seen 
that the relationship between the Ca
2+
 concentration and MLCK activation is 
relatively steep at these Ca
2+
 levels. This result is also qualitatively consistent with 
experimental observations that have shown large changes in active force production 
for relatively small changes in Ca
2+
 levels (Ozaki et al., 1991a; Ozaki et al., 1991b). 












Figure 3.22. Myosin phosphorylation produced in response to the two Ca2+ 
transients shown in Figure 3.21. Increasing Camax by 50% resulted in a 203.4% 
increase in the peak levels of myosin phosphorylation. This can be attributed to 
the steep relationship between the Ca2+ concentration and MLCK activation at 
these Ca2+ levels. 
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3.4.3 Simulation of Phasic Contraction 
Upon myosin phosphorylation, active force is generated through the formation of 
cross-bridges (AMp) and latch-bridges (AM). As mentioned in Section 3.3, active 
force (F) can be considered to be proportional to the number of cross-bridges and 
latch-bridges [31] and based on this premise, the fraction of attached cross- and latch-
bridges, N, was used as an estimate of the resultant force. For N, a value of zero 
indicates the absence of any cross- or latch-bridges, and a value of one indicates the 
production of a maximal force where all myosin heads are bound to actin. The 
simulated normalized force for the prescribed input calcium signal generated by 
Equation 3.11 with a [Ca
2+
]max of 0.6 µM and compared to experimental force values 
from Ozaki et al. (1991a) is shown in Figure 3.23. 
The simulated force exhibited some of the key characteristic features of the 
contraction patterns observed through experiments done at tissue and cellular level 
(Himpens and Somlyo, 1988; Yagi et al., 1988; Ozaki et al., 1991a; Ozaki et al., 
1991b). Contraction was initiated after a short delay of 60 milliseconds following the 
rise in cytosolic Ca
2+
 and the maximum generated force also lagged behind the Ca
2+
 
peak by 180 milliseconds. Yagi et al. (1988) showed several-hundred millisecond 
delay between stimulation and onset of force development. Yagi et al. (1988) 
attributed this delay to the step(s) linking Ca
2+
 and myosin light chain phosphorylation 
because a delay of several hundred milliseconds was seen between stimulation and the 
first significant increase in myosin light chain phosphorylation. The model results 
showed a 40 millisecond delay between rise in Ca
2+
 and increase in myosin 
phosphorylation and 160 millisecond delay between Ca
2+
 peak and myosin 





 and occurred at a faster rate. The resting force between the phasic 





This provides the basal tone onto which the phasic contractions are superimposed.  
 
 
Figure 3.23. Normalized force predicted by the model for the prescribed Ca2+ 
transient with a [Ca2+]max of 0.6 µM. The simulated normalized force values 
(solid line) are compared to experimental force data (dotted line) in the first cycle. 
The Ca2+ transient (dashed line) was generated by Equation 3.11. Contraction 
was initiated after a short delay following the rise in cytosolic Ca2+ and the 
maximum generated force also lagged behind the Ca2+ peak. Mechanical 
relaxation preceded the decline of cytosolic Ca2+ and occurred at a faster rate. 
Phasic contractions are superimposed on a non-zero resting tone. These are some 
of the characteristic features of the contraction pattern observed through 
experiments done at tissue and cellular level. 
 
 












































(Ozaki et al., 1991a) 
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3.4.4 Effect of MLCP Concentration 
As mentioned earlier in the Section 3.3, only the dynamic changes in MLCKactive are 
explicitly described and the MLCP concentration was assumed to be constant. With 
no direct data for the amount of MLCP in smooth muscle cells, the concentration of 
MLCP had to be estimated through fitting as explained in Section 3.3. Th effect of 
changing the MLCP concentration on the force values is shown in Figure 3.24 for two 
contant values of MLCP concentration. Varying the constant concentration value of 
MLCP altered the rate of relaxation and the amplitude of the force. 
To study the effect of the MLCP concentration on the dynamics of cross-bridge 
formation, the normalized force values for each MLCP concentration were normalized 
to their respective maximum values and compared as shown in Figure 3.25. It was 
observed that changing MLCP concentration had an effect on both the onset of force 





Figure 3.24. Effect of the MLCP concentration on the normalized force values. 
Changing the MLCP concentration has an effect on the amplitude of the force 
values and the relaxation phase. 
 
 
Figure 3.25. Effect of the MLCP concentration on the normalized force values. 
The normalized force values for each MLCP concentration are shown relative to 
their respective maximum values to facilitate comparison. Changing the MLCP 
concentration has an effect on both the onset of force development and the 
relaxation phase. 
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In summary, the relationship between calcium and active force production depends on 
the level of myosin phosphorylation and cross-bridge formation. Myosin 
phosphorylation depends on the activities of MLCK and MLCP. Activation of MLCK 
is regulated by the intracellular calcium concentration and also depends on the 
concentration of CaM. The cooperativity between the three binding sites of CaM 
regulates the dynamic relationship between Ca
2+ 
and MLCK activation. The 
availability of CaM influences the level of MLCK activation.  
To validate the model, simulations were run using a second independent set of data. 
Here, forces measured from spontaneously contracting canine antrum SM, as shown 
in Figure 3.23, were simulated (Ozaki et al., 1991a). The phasic contractile behavior 
predicted by the model shows a good qualitative agreement with the experimental 
observation as (Figure 3.23). The experimental force results available for gastric SMC 
have their corresponding [Ca
2+
]i values reported in terms of the fluorescence ratio. 
Lack of actual Ca
2+ 
concentration data or the calibration details, has made it difficult 
to validate the model in terms of quantitative agreement. However the [Ca
2+
]i values 
assumed are well within the working range of [Ca
2+





3.5. Function based description for Module I 
The steady state relationship between [Ca
2+
]i and MLCK activity has been observed to 
follow a sigmoidal relationship (Gallagher et al., 1991; Persechini et al., 1994; 
Gallagher et al., 1997; Persechini and Cronk, 1999; Geguchadze et al., 2004) and can 
be described by a mathematical function (Bursztyn et al., 2007). Similar to a detailed 
pathway description, a sigmoid function can describe the relationship between [Ca
2+
]i 
and MLCK activation over a given Ca
2+
 range. Bursztyn et al. (2007) developed a 
uterine SM contraction model based on Hai and Murphy’s model using a function to 
describe MLCK activation (Bursztyn et al., 2007). Motivated by the simple 
implementation, a function based description for Module I was developed for gastric 
SM contraction. While Bursztyn et al. (2007) described the parameter K1, which is the 
rate of phosphorylation of myosin light chain in the Hai and Murphy’s four state 
model, as a direct function of [Ca
2+
]i, in this study the concentration of MLCKactive has 
been made a function of [Ca
2+
]i.   
Using fluorescent biosensor studies, the relationship between free Ca
2+
 and MLCK 
activation has been determined (Kasturi et al., 1993; Johnson et al., 1996; Persechini 
and Cronk, 1999; Geguchadze et al., 2004). MLCK activation increased with increase 
in intracellular [Ca
2+
]i in a sigmoidal manner and started to reach steady state at 
approximately 5 µM free [Ca
2+
]i (Persechini and Cronk, 1999). Based on the available 
data on Ca
2+
 concentration and MLCK activation, a direct function was adopted based 





                  
       
        
 
         




]50 is the intracellular free calcium concentration producing half of the 
maximum activation of MLCK, and n is the Hill coefficient describing cooperativity 
between the binding molecules, here calcium and CaM bound MLCK. The Equation 
3.12 can be considered to be a bundled description of the binding of four Ca
2+
 ions to 




Since the availability of CaM is the limiting condition in the activation of MLCK 
(Persechini and Stemmer, 2002), the concentration of CaM available for MLCK 
activation has been incorporated into Equation 3.12. The parameters of Equation 3.12 
were determined from the experimental data from Persechini A et al. (Persechini and 
Cronk, 1999) (shown in Figure 3.3) and the values of [Ca
2+
]50 and n are 1.149 µM and 
2.376 respectively. The experimental results showed the relationship between 
intracellular free [Ca
2+
]i and free (Ca
2+
)4CaM in the presence of two indicator proteins 
(FIP-CBSM-38 and FIP-CBSM-41) with the peptide sequence of myosin light chain 
kinase and varying affinities. FIP-CBSM-38 has low affinity with Kd= 45 nM and FIP-
CBSM-41 has a high affinity of Kd= 2 nm. From the experimental results, the amount of 
(Ca
2+
)4CaM bound to MLCK can be estimated as the difference between the amount 
of free (Ca
2+
)4CaM concentration in the presence of low affinity protein FIP-CBSM-38  
and the amount free (Ca
2+
)4CaM concentration in the presence of high affinity protein 
FIP-CBSM-41. By fitting the Hill equation (Equation 3.12) to the difference between 
these results, the parameters of the Equation 3.12 were estimated. The MLCKactive 
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concentration for a CaM concentration of 5.5 µM (the total CaM concentration used in 
pathway model) was estimated at various Ca
2+
 concentrations in a given range.  
 
3.5.1 Results and Discussion 
The steady state behavior of MLCKactive predicted by the function model differed from 
the behavior predicted by the pathway model as shown in Figure 3.26. The difference 
can be attributed to the difference in the method of fitting the parameters in function 
based model and the pathway model.   
 
 
Figure 3.26. Comparison of steady state relationship between [Ca2+]i and MLCK 
activation between pathway based model and function based model. The function 
based model fitted to data from Persechini A and Cronk (1999) shows a slower 
rate of MLCK activation compared to the MLCK activation result from pathway 
model. 
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The MLCKactive concentration estimated by Equation 3.12 was used in Equations 3.3- 
3.6 in Module II (Section 3.2.2) to predict the force generation in response to the 
given calcium. In the uterine contraction model, the rate of phosphorylation of myosin 
light chain by MLCK was defined as a Hill function of [Ca
2+
]i (Bursztyn et al., 2007). 
In the current model, MLCK active concentration is estimated through Hill function 
and then rate of phosphorylation is computed using Henri-Michaelis-Menten kinetics 
as explained in Section 3.3. 
The function based model was then simulated with the prescribed calcium transient 
with [Ca
2+
]max value of 0.6 µM and the phasic force response is shown in Figure 3.27. 
 
 
Figure 3.27. Simulated normalized force for the prescribed [Ca2+]i transient with 
a [Ca2+]max of 0.6 µM. The total CaM concentration (5.5 µM) in pathway model 
was used as the concentration of CaM available for MLCK activation.  
 







































With 5.5 µM of calmodulin concentration ([CaM] in Equation 3.12), which is the total 
CaM concentration used in the pathway model, the function based model produced a 
maximum normalized force (6.3%) which was less than the maximum normalized 
force produced by the pathway model (17.04%) (Figure 3.23 and Figure 3.27).  
Increasing the [CaM] concentration to 12.395 µM produced normalized force with the 
peak equal to the one produced by the pathway model. A comparison between the 
normalized force results with the same peak value from the function model and 
pathway model show that, the onset of force development is faster in the function 
model inspite of a slower MLCK activation rate in the steady state condition and the 
resting force is greater than the resting force in the pathway model. 
 
 
Figure 3.28. Comparison between normalized force produced by the function 
based model (solid line) and the pathway model (dashed line). The onset of force 
development is faster in the function model and the resting value is greater than 
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  Simulated normalized force
  from pathway based model
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The function based model was next tested with an experimental Ca
2+
 transient from 
Ozaki et al. (1991a) and compared with the experimental force values.  
 
 
Figure 3.29. Normalized force from the function based model (solid line) for a 
given experimental Ca2+ transient (dashed line) from Ozaki et al. (1991a) is 
compared to the experimental normalized force values (dotted line). MLCP 
concentration of 7 µM used for the pathway model was used here in the function 
based model.  
 
In Figure 3.29, it can be seen that the onset of force in the function based model 
precedes the experimental force. With the experimental force normalized to the peak 
force value from the model, the model shows a higher resting values compared to the 
experiment. The normalized force values during the relaxation phase were greater 
compared to the experimental force values. Increasing the MLCP concentration did 
not accelerate the relaxation phase as shown in Figure 3.30 for increased MLCP 
concentration of 10 µM.  
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Figure 3.30. Normalized force from the function based model (solid line) for a 
given experimental Ca2+ transient (dashed line) from Ozaki et al. (1991a) is 
compared to the experimental normalized force values (dotted line). An increased 
MLCP concentration of 10 µM affected only the amplitude of the force and did 
not have an effect on the relaxation phase. 
 
The effect of MLCP concentration on normalized force predicted by the function 
based model was studied with three different MLCP concentrations as shown in 
Figure 3.31. As the change in MLCP concentration affected the amplitude of the force 
values, the normalized force values were reported in relative to their maximum value 
to facilitate the comparison of the effect of MLCP on the relaxation phase. It was seen 
that MLCP concentrations greater than 7 µM had no significant effect on the 
relaxation phase. Hence, increasing the MLCP concentrations did not solve the 
problem of fitting the relaxation phase of the normalized force from the model to the 
experimental force values. 
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Figure 3.31. Effect of MLCP concentration on normalized force predicted by the 
function based model. The normalized force values are reported in relative to 
their maximum value to facilitate the comparison of the effect of MLCP on the 
relaxation phase. It is seen that MLCP concentration greater than 7 µM had no 
significant effect on the relaxation phase. Hence increasing the MLCP 
concentration did not solve the problem of fitting the relaxation phase of the 
normalized force from the model to the experimental force values. 
 
This can be attributed to the MLCK activation dynamics in the function based model. 
The MLCKactive concentration produced by the function based model and the pathway 
model for a given Ca
2+
 transient are compared in Figure 3.32. Under transient 
conditions, MLCK activation in function based model was rapid and greater compared 
to the pathway model. The MLCKactive concentration values have been normalized to 
their maximum value, since the values depend on the CaM concentration and the same 
total CaM value in function based model and pathway model produce different 
MLCKactive concentrations. In Figure 3.32, the MLCKactive concentrations produced by 
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the pathway model and function based model were normalized to their respective 
maximum values and compared to study their temporal dynamics with respect to the 
Ca
2+
 transient dynamics. 
 
 
Figure 3.32. MLCKactive concentration (normalized to their maximum values) 
produced by the function based model (solid line) and the pathway model (dotted 
line) for a give Ca2+ transient (dashed line). It is seen that under transient 
conditions, MLCK activation in function based model is rapid and greater 
compared to the pathway model.  
 
Though the function based model is able to predict the sigmoidal steady state 
relationship between MLCK activation and Ca
2+
 concentration, under transient 
conditions, the results differ from the pathway results. From Figure 3.32, it can be 
seen that under transient conditions, MLCK activation in function based model is 
rapid and greater in amplitude compared to the pathway model. Since MLCKactive 
concentration is estimated at each [Ca
2+
] (t) value, the function based model is not 






























































able to show the time delay between rise in [Ca
2+
]i and the onset of rise in MLCKactive 
levels. Hence the onset of contraction is rapid in the simulations from the function 
based model compared to the onset of force development in the experimental data and 
the pathway based model. Though function based model is a comparatively simple 
description of MLCK activation and is capable of predicting the phasic contractile 
behavior for a given [Ca
2+
]i transient, it has its limitations in predicting the temporal 
dynamics of the force behavior. 
 
3.6. Summary 
In this Chapter, the implementation of a pathway description for the Ca
2+ 
dependent 
activation of MLCK is explained by describing the interactions between Ca
2+
, CaM 
and MLCK. MLCK, upon binding to (Ca
2+
)4CaM, gets activated and forms the active 
enzyme complex (MLCKactive). For a given Ca
2+
 concentration, the model predicts the 
activation level of MLCK. A direct function based model for MLCK activation has 
also been implemented and tested. MLCKactive phosphorylates myosin light chain and 
enables cross-bridge formation between myosin and actin. According to sliding 
filament theory, cross-bridge formation leads to contraction of the SMC. MLCP on the 
other hand dephosphorylates myosin light chain and leads to detachment of the cross-
bridges and hence relaxation of the SMC. MLCK activity and MLCP activity together 
with the cross-bridge cycling kinetics predict the fraction of total myosin forming 
cross-bridges with actin.  From evidence in the literature, force was made proportional 
to the number of cross-bridges formed and the phasic force response elicited by 
transient [Ca
2+
]i was simulated using the model.  With descriptions for the electrical 
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activity of single gastric SM cells predicting the intracellular Ca
2+
 dynamics, the 
model provides a framework to study electro-mechanical coupling. 
MLCK activation is the central mechanism in contraction of SMCs. One of the 
significant components of the model is the role of calmodulin and the properties of its 
three binding sites in regulating MLCK activation.  CaM content has been reported to 
vary between different cell types. The effect of the CaM concentration on MLCK 
activation (Figure 3.8) shows the need for estimation of CaM content (bound and free) 
in specific cell types.  The difference in the results from the preliminary and the 
extended pathway models, show how the binding dynamics between proteins 
influence the activities of the proteins. Module I has shown the active role of CaM in 
the MLCK activation pathway than just being a passive conduit for intracellular Ca
2+
. 
Replacing the fixed rate constants for phosphorylation and dephosphorylation in Hai 
and Murphy’s model with Henri-Michaelis-Menten’ enzyme kinetics has enabled the 
study of regulation of myosin phosphorylation by MLCK and MLCP.  Almost all the 
pathways mediating contraction through regulation of myosin phosphorylation, 
impose a positive or negative feedback on the activity of either MLCK or MLCP.  
While MLCK has been studied extensively, there is lack of data on the cellular 
content of MLCP and activity of MLCP in SMCs. Hence, the concentration of MLCP 
had to be estimated and the effect of MLCP on the model behavior (Figure 3.24) 
shows it is a key player in Module II of the model. 
The cross-bridge cycling kinetics has been retained the same way as in the Hai and 
Murphy model. They are defined by the fixed parameters K3 and K4. Few studies have 
suggested time dependent variation in the cross-bridge cycling kinetics with a slower 
detachment rate during force maintenance in tonic SMCs (Arner and Hellstrand, 1983; 
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Hellstrand and Nordstrom, 1993; Vyas et al., 1994). Though this has not been 
addressed in the model at this stage due to lack of specific data for phasic SM, a more 
detailed description of the cross-bridge cycling kinetics would be a significant 
improvement to the existing four-state model. 
In summary, the main objective of this chapter is to describe the link between Ca
2+
, 
MLCK activation, myosin phosphorylation and cross-bridge formation. This has been 
achieved by bringing together two sets of experimental data: the relationship between 
Ca
2+ 
and MLCK activity and the relationship between Ca
2+
 and force.  The link 
between Ca
2+
 and force observed at single cell level has been established by 
describing the Ca
2+





4. SMC relaxation mediated through MLCP regulation  
4.1. Introduction 
According to the MLCK activation model of active force production relaxation is 
brought about by a reduction in intracellular calcium and consequent decrease in 
MLCK activity. However, studies have shown that the fall in tension is faster than 
would be predicted by calcium decline and MLCK inactivation alone (Yagi et al., 
1988; Ozaki et al., 1991a). Yagi et al. (1988) observed an uncoupling of force from 
the activating stimulus and a desensitization to calcium. The greater rate of muscle 
relaxation compared to the rate of decline in [Ca
2+
]i can be attributed to this 
uncoupling. This suggested that, in addition to events following a decline in calcium, 
secondary mechanisms may play a regulatory role in the relaxation of SMC.  
In Chapter 3 it was assumed that the MLCP concentration was constant. However, 
recent data have indicated pathways and molecules that inhibit or activate phosphatase 
activity under certain conditions (Yagi et al., 1988; Somlyo and Somlyo, 1994; 
Hartshorne et al., 1998; Hartshorne et al., 2004). Studies have been carried out to 
characterize the type of phosphatase that is present in smooth muscle cells and is 
capable of binding to myosin and dephosphorylating the myosin light chains (Shirazi 
et al., 1994; Huang et al., 2004).  Though the studies have yielded sometimes 
confounding results, pointing to more than one type of phosphatase, most of the 
results have pointed to type I phosphatase activity in SMCs.  Biochemical and gene 
sequencing studies have shown that type I phosphatase consists of three main sub-
units: (i) 38 kDa catalytic subunit called PP1cδ, (ii) 110 kDa – 133 kDa target binding 
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subunit called MYPT1, and (iii) a 20 kDa subunit with an unknown regulatory 
function (Ichikawa et al., 1996; Hartshorne et al., 1998; Khatri et al., 2001; 
Hartshorne et al., 2004; Matsumura and Hartshorne, 2008). Modification of the PP1c 
subunit or the MYPT1 subunit alters the activity of the enzyme and/or binding of 
substrate to the enzyme.  
Based on experimental evidence that MLCP is indeed regulated and 
dephosphorylation of myosin is caused by the phosphatase enzyme, the rapid 
relaxation due to a greater dephosphorylation rate compared to the decline of calcium 
in phasic SM cells can be attributed to activation of MLCP. The activation of MLCP 
can be considered to happen in two ways: i) direct activation of MLCP, and ii) down 
regulation of the pathways inhibiting MLCP activity.  
MLCP activation by telokin: Phenotyping of the contractile properties of tonic and 
phasic SM has given insight into the presence of a 17-kDa acidic protein called telokin 
that is expressed exclusively in smooth muscle cells (Hong et al., 2009). Telokin is 
expressed at very high levels in intestinal, urinary, and reproductive tract smooth 
muscle, at lower levels in vascular smooth muscle, and at undetectable levels in 
skeletal or cardiac muscle and non-muscle tissues (Gallagher and Herring, 1991; 
Herring et al., 2006; Khromov et al., 2006; Mahavadi et al., 2008). The tissue specific 
differential expression of telokin suggests that the protein may play a physiological 
role in the smooth muscle cell function. Wu et al (1998) showed that the major in situ 
effect of telokin was desensitization to [Ca
2+
]i through a mechanism that does not 
affect phosphorylation but accelerates the dephosphorylation of the myosin light 
chains. The high abundance of telokin in phasic smooth muscles compared to tonic 
smooth muscles and the observed higher phosphatase activity of phasic smooth 
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muscle reflect a possible link between telokin and phosphatase activity (Gong et al., 
1992a). Studies have implicated telokin in the activation of MLCP in SMC (Wu et al., 
1998; Walker et al., 2001; Choudhury et al., 2004; Khromov et al., 2006). However 
the mechanism of activation has not yet been established. 
The mylk1 gene encodes at least four protein products: two isoforms of the 220-kDa 
MLCK, a 130-kDa MLCK, and telokin (Herring et al., 2006). Transcripts encoding 
these products are derived from four independent promoters within the mylk1 gene. 
High levels of telokin transcription in phasic smooth muscle cells is mediated by a 
combination of cell- and tissue-restricted factors, acting together with more general 
transcription factors. Among different smooth muscle tissues, unique but overlapping 
sets of transcription factors have been found to direct high levels of telokin expression 
(Herring et al., 2006).  
Sobieszek et al., (2005) isolated actomyosin filament structures that contain 
endogenous CaM, MLCK and MLCP complexes. Purified myosin filaments have also 
been shown to contain endogenous CaM, MLCK and MLCP. Protein purification and 
sedimentation techniques have quantified the molar ratio of the molecules. The study 
has also shown the presence of telokin at a high molar ratio with myosin. When 
[Ca
2+
]i & ATP were added to the actomyosin filament preparation, phosphorylation 
and dephosphorylation of the myosin light chains were observed similar to the 
contraction-relaxation cycle observed in intact smooth cells & tissue preparations. 
During in vitro studies done on intact actomyosin structures and purified myosin 
filaments, telokin has been found to increase the dephosphorylation rate of the myosin 
light chains (Sobieszek et al., 2005). It has been suggested that telokin modulates the 
dephosphorylation of myosin by activating the endogenous MLCP associated with 
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actomyosin structure. This argument is plausible since MLCP is the key regulatory 
enzyme causing the dephosphorylation of myosin light chains. There are conflicting 
reports on the effect of telokin on MLCK activity. While Sobieszek et al (2005) claim 
that it inhibits the phosphorylation event mediated by MLCK, Khromov et al (2006) 
and Choudhury et al (2004) have shown that it does not affect the phosphorylation of 
myosin. Various mechanisms for telokin’s contribution have been tested. One of the 
possible modes of action being probed is the binding of telokin with the myosin 
filament structure and its contribution to the conformation state of the myosin 
filaments (Sobieszek et al., 2005; Hong et al., 2009). According to this argument, 
telokin acts on the substrate (myosin filaments) rather than on the enzymes (MLCK 
and MLCP) per se. There are reports on the ability of telokin to dimerize the MLCK 
complex causing activation of the phosphatase enzyme in the complex (Sobieszek et 
al., 2005). 
It should be noted that most of the above mentioned observations made on telokin 
have been obtained from studies done in vitro (Wu et al., 1998; Walker et al., 2001; 
Choudhury et al., 2004; Sobieszek et al., 2005).  One of the significant works on 
telokin done in vivo by investigating telokin knockout mice has demonstrated the 
importance of telokin in regulating the relationship between [Ca
2+
]i and force 
(Khromov et al., 2006).  The important finding of the experiments was that in telokin 
deficient mice, a marked decrease in myosin phosphatase activity was observed along 
with a significant leftward shift in the [Ca
2+
]i-force relationship and an increase in 
myosin phosphorylation as compared to wild-type mice. These experiments were 
performed in the phasic phenotypic SM (ileal SM). However in tonic SM (aortic SM), 
there were no significant changes due to the telokin deficiency.  Contrary to the results 
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from in vitro studies, there was no marked effect of telokin deficiency in the assembly 
and conformation of myosin filaments in the cell (Sobieszek et al., 2005). 
The in vivo study showed a 0.3 pCa units leftward shift in the force calcium curve in 
telokin knockout (KO) ileal SM and a 2-fold greater force for a given [Ca
2+
]i over the 
physiologically relevant steep portion of the force curve. The effect was nearly 
completely rescued by the addition of 15 µM S13D recombinant telokin. Hence the 
observed shift cannot be attributed due to any adaptive changes in expression of 
contractile proteins that occurred secondary to knockout of telokin. Telokin did not 
alter the calcium induced force development caused by activation of MLCK when 
MLCP (MYPT1) was inhibited by microcystin. Hence it can be inferred that telokin’s 
action of accelerating the myosin dephosphorylation is not through inhibition of 
MLCK activity.  
Under the condition that neither MYPT1 (subunit of MLCP) or MLCK content 
differed in the telokin knockout mice and wild-type mice, the reduction in the rate of 
relaxation in SM of knockout mice and the rescue of the effect by addition of 
recombinant telokin,  support the theory of activation of MLCP by telokin. Figure 4.1 
shows the effect of addition of recombinant telokin to telokin KO ileal SM on the 
relaxation phase of Ca
2+
 induced contraction. However the temporal dynamics of 





Figure 4.1. Relaxation of Ca2+ induced force was significantly accelerated in 
telokin KO ileal SM upon addition of 10 µM of recombinant telokin. At the 
plateau phase of the Ca2+ induced force trace, MLCK activity was inhibited by 
the addition of MLCK inhibitor. The rate of relaxation was taken as an index of 
in vivo MLCP activity which is accelerated by the addition of recombinant 
telokin (Khromov et al., 2006). 
 
The expression and role of telokin has thrown light on the differences in protein 
content between different SM types contributing to the phasic and tonic phenotype. 
Quantification of telokin content has shown that it is expressed in abundance (27 ± 4.6 
µM) in phasic type of SMCs while it is present in very low levels in tonic SMCs (6 ± 
1.7 µM) (Khromov et al., 2006). An interesting observation is that the calcium-force 
relationship of the telokin knock-out mice was similar to the wild-type aortic SM 
calcium-force relationship.  Hence, it can be said that telokin and its suggested 
activation of MLCP contribute for the observed difference in the [Ca
2+
] - force 
relationship and contractile behavior between phasic and tonic SMCs.  This also 
points to a general mechanism of smooth muscles’ regulation in which the contractile 
properties of different smooth muscle are likely to be dictated by the expression levels 
of distinct subsets of signalling proteins.  
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Inhibition of MLCP: Most of the studies made on MLC phosphatase indicate two 
events that inhibit MLCP: i) phosphorylation of MYPT1, and ii) binding of a molecule 
called CPI-17 as a result of its phosphorylation to PP1c subunit (Gong et al., 1992a; 
Shirazi et al., 1994; Somlyo and Somlyo, 1994; Hartshorne et al., 1998; Richards et 
al., 2002; Hartshorne et al., 2004; Murthy, 2006; Lincoln, 2007; Mahavadi et al., 2008; 
Ohama et al., 2008). Inhibition of MLCP has been found to be mainly linked to 
agonist stimulation of SMC via numerous GPCRs and RhoA mediated pathways 
(Gong et al., 1992b; Richards et al., 2002; Hirano et al., 2003; Murthy, 2006).  
However, under conditions of electrical excitation and depolarization, there is no 
strong evidence for MLCP inhibition. Since the current model focuses on electro-
mechanical coupling and not pharmaco-mechanical coupling (stimulation by agonists), 
inhibition of MLCP is beyond the scope of this work. Studies have indicated the 
activation of MLCP by inhibition/downregulation of the MLCP inhibitory pathways 
(Ichikawa et al., 1996; Huang et al., 2004; Lincoln, 2007; Paul, 2009). PKA & cGK 
have been suggested to inactivate the inhibitory RhoA/ROK pathway and hence 
activate the MLCP. A possible role for telokin in activation of PKA & cGK has also 
been reported (Walker et al., 2001; Khromov et al., 2006). 
 From the available literature on MLCP regulation, a direct relationship between 
calcium and MLCP regulation cannot be established. However, from an analysis of 
the pathways leading to MLCP regulation and experimental results showing the 
temporal dynamics of calcium and force response, it can be argued that Ca
2+
 and/or 
the pathways leading to an increase in intracellular Ca
2+
, through secondary 




4.2. MLCP regulation hypothesis 
In antral smooth muscles, it has been demonstrated that the muscle force and MLC20 
phosphorylation decrease more rapidly than the decline in [Ca
2+
]i after the peak phasic 
contraction (Ozaki et al., 1991a). This phenomenon may be due to a Ca
2+
 dependent 
and time dependent decrease in the [Ca
2+
]I sensitivity of the contractile apparatus 
during phasic contractions. Such dissociation between [Ca
2+
] and force has been 
reported in phasic and mixed smooth muscles. Yagi et al. (1988) observed a shift in 
the coupling of the [Ca
2+
]i signal and force production occurring in a time-dependent 
manner after the activation. Yagi et al. (1988) also found that Ca
2+
 sensitivity 
decreased with time in spontaneously contracting gastric smooth muscle cells. 
Himpens et al. (1989) reported that Ca
2+
 sensitivity decreased during the contraction 
relaxation cycles in guinea pig ileum muscle. 
There is compelling evidence in the literature that force is more closely related to 
phosphorylation than Ca
2+
. The fall in force has been observed to have good 
correlation with the rate of dephosphorylation rather than the rate of decline in [Ca
2+
]i 
concentration (Ozaki et al., 1991a).  Ozaki et al (1991a) suggested that the 
relationship between [Ca
2+
], myosin phosphorylation and contraction changes as a 
function of [Ca
2+
] in canine antral muscles and this may be due to a Ca
2+
 and time 
dependent phosphatase that regulates the level of myosin phosphorylation. 
MLCK and MLCP are the two prominent players in regulating the contraction-
relaxation cycle in SMC. The net phosphorylation and hence the force depends on the 
dynamic ratio between MLCK and MLCP activity (Gong et al., 1992a; Choudhury et 
al., 2004). Inhibition of smooth muscle phosphatase(s) using calyculin-A, a type-I 
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phosphatase inhibitor showed the abolition of one phase of relaxation in the smooth 
muscle as shown in Figure 4.2. The study clearly indicated the role of phosphates(s) in 
the relaxation phase of phasic contractions. The phosphatase inhibitor calyculin-A 
caused a significant increase in myosin phosphorylation without changing the Ca
2+
 
transient. Hence the change in the contractile behavior in the presence of calyculin-A 
is effected through a change in myosin phosphorylation levels. Ozaki et al (1991) 
hypothesized presence of two types of phosphatases with the calyculin-A insensitive 
phosphatase(s) (type-2B phosphatase) regulating the initial phase of relaxation and a 
calyculin-A sensitive type-I phosphatase causing the second phase of relaxation as 
seen in Figure 4.2. 
 
  
Figure 4.2. Effect of MLCP inhibitor (calyculin-A) on [Ca2+]i, muscle tension 
and MLC phosphorylation.Ca2+ transients and phasic contractions are displayed 
under control condition (0%) and during the presence of calyculin –A (at 68% of 
peak response) and at the maximal response to calyculin-A (100%). The initial 
phase of relaxation of the phasic contractions was not affected by calyculin-A, 
but the later phase was markedly reduced. The average level of MLC 
phosphorylation also increased in response to calyculin-A as shown by the bar 
graph. The change in the contractile behavior is correlated to the change in 
myosin phosphorylation due to MLCP inhibition (Ozaki et al., 1991a). 
 
Figure 4.2 shows the effect of MLCP inhibition using calyculin-A in canine antral SM 
(Ozaki et al., 1991a). A complete inhibition of MLCP in the model produced a steady 
state force. Hence 50 nM of MLCP was used to simulate the condition of MLCP 
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inhibition. Figure 4.3 shows the force behavior under 7 µM of MLCP and 50 nM 
MLCP. Under very low MLCP conditions, decreased myosin dephosphorylation lead 
to increase in the amplitude of the force and slower relaxation to the resting state 
compared to the control condition.  In the model with low [MLCP], the relaxation is 
predominantly caused by the MLCK inactivation in response to decrease in [Ca
2+
]i 
and the cross-bridge cycling caused by the low levels of MLCP.   
 
 
Figure 4.3. Effect of reduced MLCP concentration on the contractile behavior. A) 
Normalized force with a constant MLCP concentration of 7 µM showed rapid 
relaxation to the resting value. B) Normalized force with a constant MLCP 
concentration of 50 nM showed increase in the amplitude of force and greatly 
reduced relaxation. 
 
From MLCP inhibitory studies, Ozaki et al (1991a) suggested that dephosphorylation 
of myosin may be accelerated in phasic smooth muscles causing rapid relaxation and 
the myosin dephosphorylation may be regulated by MLCP. However no studies have 
been done so far to estimate the amount of MLCP in SMCs during active contraction.  
Based on the knowledge that MLCP is being regulated by intracellular proteins 
(Section 4.1) and dephosphorylation of myosin in phasic SMCs is regulated by MLCP, 
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a hypothesis for MLCP regulation is proposed. According to our hypothesis, a Ca
2+
 
and time dependent regulation of MLCP concentration leads to the regulation of 
dephosphorylation and hence relaxation in phasic SMCs. 
Analyzing the [Ca
2+
]-force behavior reported in the experimental results (Yagi et al., 
1988; Ozaki et al., 1991a) and the predictions made from our model with only MLCK 
activation (Chapter 3), a mathematical formulation for MLCP regulation as function 
of Ca
2+
 and time is proposed as an embodiment of this hypothesis. 
 
4.3. MLCP regulation model 
Though telokin is associated with MLCP activation, there is no data in the literature as 
to the mechanism of activation. Also, no quantitative data on the dynamics of MLCP 





 and time dependent variation in MLCP concentration is assumed to be 
causing rapid relaxation and a feedback equation regulating MLCP concentration is 
proposed.   
 
 
       
  
                      (4.1) 
 
The parameters control the concentration of MLCP with A controlling the amplitude 
of activation and ω (=1/τ) representing the time constant of MLCP activation. From 
Equation 4.1, the concentration of MLCP as a function of time and [Ca
2+
]i can be 
predicted and linked to the Module II of the muscle model in Equations 3.3-3.6 
(described in Section 3.2.2).  The parameter, ω in Equation 4.1 was estimated using 
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the in-built MATLAB function “fminsearch” as described in the previous chapter 
(Section 3.2.2).  The force data from Ozaki et al (Ozaki et al., 1991a) shown in Figure 
3.9 was used for fitting the parameter value. The value of the parameter, A, was 
derived from the telokin concentration in phasic SM cells.  By linking MLCP 
activation to the telokin concentration in the SMCs through the parameter ‘A’, the 
amplitude of MLCP activation was made suggestive of the telokin level in the cell. 
The values of A and ω were 27.4 and 2.5 s-1 respectively. 
The MLCP dynamics predicted by Equation 4.1 for a given Ca
2+
 transient are shown 
in Figure 4.4. In the absence of experimental data, MLCP concentration was 
determined by Equation 4.1 using the parameter values estimated through fitting force 
values as shown in Figure 4.6. The concentration of MLCP increases from a basal 
resting value with increase in Ca
2+
 concentration and reaches a peak when Ca
2+
 
concentration falls to 20% of its peak value. 
The MLCP dynamics is shown in comparison to MLCK activation in Figure 4.5. It 
can be seen that peak of [MLCP] follows the peak of [MLCKactive].    The ratio 
between [MLCKactive] and [MLCP] is dynamically altered with time as a function of 
change in Ca
2+
 concentration. This ratio determines the phasic contractile behavior in 
the SMC. As seen in Figure 4.4 low levels of MLCP during the onset of Ca
2+
 increase, 
lead to rapid initiation of contraction. The steep increase in MLCKactive levels leads to 
rapid contraction with the peak myosin phosphorylation and contractile force 
corresponding to the peak in MLCKactive levels.  The [MLCP] peak following the peak 
in [MLCKactive] with a time delay leads to rapid dephosphorylation of myosin and 





Figure 4.4. The change in [MLCP] as a function of Ca2+ described by Equation 
4.1. The concentration of MLCP increases from a basal resting value with 
increase in [Ca2+]i and reaches a peak when Ca
2+ concentration falls to 20% of its 
peak value.  
 
 
Figure 4.5. MLCP dynamics shown in comparison to MLCK activation. It can be 
seen that peak of [MLCP] follows the peak of [MLCKactive].    The ratio between 
[MLCKactive] and [MLCP] is dynamically altered with time as a function of 
change in [Ca2+]i. 

























































































Figure 4.6. Normalized force produced by the model with [MLCP] regulation. 
The corresponding Ca2+ transient (dash dotted line) and normalized experimental 
force (dotted line) are shown. 
 
The model with MLCP regulation (Figure 4.6) gave a better fit with the experimental 
data compared to the model with [MLCP] held constant (Figure 3.18).  The relaxation 
was faster in the [MLCP] regulated model. The t1/2 for relaxation was 1.28 seconds in 
the [MLCP] regulated model and 1.39 seconds in the constant [MLCP] model. Ozaki 
et al. (1991a) reported a t1/2 value of 1.1 seconds for relaxation as seen in the 
experimental data (Figure 4.6).  It should be noted that the peak [MLCP] (6.42 µM) 
produced by the [MLCP] regulation model (Figure 4.4) was slightly less than the 
constant [MLCP] (7.70 µM) used in Chapter 3. 
The peak force produced by the model with [MLCP] regulation was 1.78 times higher 
than the peak force produced by constant [MLCP] model. To enable comparison of 











































(Ozaki et al., 1991) 
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the temporal dynamics, the normalized force values from the [MLCP] regulation 
model and the constant [MLCP] model were normalized to their maximum values as 
shown in Figure 4.7.  
 
Figure 4.7. Normalized force for a given experimental Ca2+ transient produced by 
the model with [MLCP] regulation (solid line) and with constant [MLCP] 
(dashed line). The force values from Figure 4.6 and Figure 3.18 are expressed as 
a fraction of their maximum value. The normalized experimental force values are 
shown as dotted line. The t1/2 for relaxation was 1.28 seconds in the [MLCP] 
regulated model and 1.39 seconds in the constant [MLCP] model. The 
experimental data shows a t1/2 value of 1.1 seconds as reported by Ozaki et al 
(1991a).  
 
MLCP regulation, in addition to causing rapid relaxation, also affected the temporal 
dynamics of onset of force and the peak force. Contraction was initiated after a short 
delay of 210 milliseconds following the rise in cytosolic Ca
2+
 in the model with 
MLCP regulation while in the model with constant [MLCP], contraction was initiated 
after a short delay of 240 milliseconds. The maximum generated force also lagged 















































 peak by 60 milliseconds in the [MLCP] regulated model and by 170 
milliseconds in the constant [MLCP] model. The digitized experimental data from 
Ozaki et al. (1991a) showed a delay of 374 milliseconds in the onset of increase in 
force and 110 milliseconds delay in the peak force in comparison to Ca
2+
 transient.  
 
4.4. Effect of MLCP regulation on phasic contraction 
For a prescribed Ca
2+
 transient (Equation 3.11) with a [Ca
2+
]max of 0.6 µM, the [MLCP] 
regulation model produced the characteristic phasic contractile behavior (Figure 4.8) 
as explained in Section 3.4 similar to the constant [MLCP] model. However 
dephoshorylation and relaxation were faster in the [MLCP] regulated model as seen in 
Figure 4.11. The transient change in MLCP concentration for the prescribed Ca
2+
 data 
is shown in Figure 4.9.  
 
 
Figure 4.8. Phasic contraction produced by the [MLCP] regulated model for a 
prescribed Ca2+ transient (dashed line) with a [Ca2+]max of 0.6 µM. 










































Figure 4.9. Change in [MLCP] (solid line) for the prescribed Ca2+ transient 
(dashed line) with a [Ca2+]max of 0.6 µM. Maximum value of [MLCP] is reached 
when the Ca2+ falls to 40% of the peak value. 
 
 
Figure 4.10. Change in MLCP concentration with time in response to the Ca2+ 
transient shown in Figure 4.9. The constant MLCP concentration used in the 
model without [MLCP] regulation is shown as dashed line. The effect of 
changing [MLCP] and constant [MLCP] on myosin phosphorylation and force is 
shown in Figure 4.11. 





























































The effect of [MLCP] on myosin phosphorylation is shown in Figure 4.11A. The 
dephosphorylation with a t1/2 of 0.73 seconds in the [MLCP] regulated model was 
slightly faster compared to the dephosphorylation with a t1/2 of 0.97 seconds generated 
by the constant [MLCP] model. Regulation of [MLCP] affects the contractile behavior 
by regulating the phosphorylation of myosin in the model. The normalized force 
values from the model with [MLCP] regulation and constant [MLCP] for one cycle of 
the prescribed Ca
2+
 transient in Figure 4.11B.  
 
   
Figure 4.11. Effect of [MLCP] regulation on myosin phosphorylation and force. 
A) [MLCP] regulation had an effect on the onset of myosin phosphorylation and 
rate of dephosphorylation. B) By regulating the myosin phosphorylation, the 
change in [MLCP] with time affected the contractile behavior as seen by the 
change in force values with (solid line) and without (dashed line) [MLCP] 
regulation. 
 
MLCP regulation resulted in an 8% reduction in the t1/2 for relaxation as shown in 
Figure 4.12 . Khromov et al., (2006) showed a 17% reduction in the t1/2 for relaxation 
when the telokin knockout ileal SM was treated with 10 µM of recombinant 
phosphorylated telokin (Figure 4.1).  
































































  With [MLCP] regulation





Figure 4.12. Dephosphorylation of myosin in the model with [MLCP] regulation 
(solid line) and constant [MLCP] (dashed line). The myosin phosphorylation 
curve for the prescribed Ca2+ transient with [Ca2+]max of 0.6 µM shown in Figure 
4.11 is re-plotted to show only the dephosphorylation phase. 
 
4.5. Summary 
In summary, a feedback equation (Equation 4.1) for regulating MLCP concentration 
has been proposed. By fitting the parameters of the equation to experimental force 
data, the MLCP dynamics were predicted for the given input Ca
2+
. The model was 
simulated with a prescribed Ca
2+
 transient and the effects of MLCP regulation on the 
myosin light chain phosphorylation and contractile behavior are studied. 
The main motivation to extend the model framework described in Chapter 3 was to 
simulate the rapid relaxation shown by experimental results.  As discussed in Chapter 
3, changing the constant value of [MLCP] did not induce rapid relaxation. From 
telokin knockout studies, a crucial link between telokin and contractile behavior has 
been established. Telokin’s role in accelerating the myosin dephosphorylation and 
hence the relaxation has been associated to activation of MLCP from MLCP activity 
assays. However the exact mechanism of MLCP activation by telokin and the mode of 











































interaction between telokin and MLCP are not yet known. Once the reaction scheme 
for MLCP activation is available, the Equation 4.1 can be modified to describe the 
reaction kinetics. 
Yagi et al. (1988) observed a shift in the coupling of the [Ca
2+
]i signal and force 
production occurring in a time-dependent manner after the activation. From the results 
it can be observed that the desensitization to [Ca
2+
]i in the form of MLCP activation is 
a slow process taking many seconds to develop and persist for few seconds after the 
decline in [Ca
2+
]i and MLCK activation. In phasic SM types such as the gastric cells 
that contract rhythmically, the relaxation event after the contraction is important for 
the proper functioning of the tissue. Hence a desensitization process could be playing 
role in the relaxation process of phasic SMCs, similar to the sensitization processes 
helping in maintenance of tone at lower [Ca
2+
]i levels in tonic SMCs (Himpens et al., 
1990; Somlyo and Somlyo, 2003). Though the results from Yagi et al. (1988) do not 
give any information about the mechanisms that might cause the desensitization, they 
strongly suggest the presence of such a regulatory mechanism causing a negative 
feedback on the force production. Here in this study MLCP regulation was 
hypothesized as the negative feedback mechanism. 
The time dependent change in MLCP concentration in addition to regulating the 
relaxation phase also had accelerated the time taken to reach the peak force. Low 
levels of MLCP at the initiation of contraction, cause rapid initiation of contraction. 
Slow increase of MLCP with the peak following the [Ca
2+
]i peak and MLCKactive peak, 
caused accelerated relaxation after the maximum force was reached.  The model 
results predict the physiologically observed phenomenon of rapid activation of 
contraction and rapid relaxation following maximum force. However the MLCP 
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regulation had only a minimal effect on the relaxation dynamics with 8% reduction in 
the t1/2 for relaxation. The model could not fully predict the fall in force near the return 
to basal tone. It is likely that there are other Ca
2+
 desensitizing mechanisms and 







5. Ca2+ induced Ca2+ desensitization. 
5.1. Regulation of Ca
2+
 Sensitivity  
Slow waves induce a transient increase in the intracellular [Ca
2+
]i concentration and a 
corresponding increase in muscle tension. Contraction is initiated after the increase in 
[Ca
2+
]i with a short delay of few hundred milliseconds and the peak of the contraction 
occurs after the peak in [Ca
2+
]i. In Chapter 3 and Chapter 4, the typical phasic 
calcium-force behavior observed in SMCs under normal slow wave depolarizations 
has been described. However, experimental conditions that induce abnormal [Ca
2+
]i 
transients, e.g., a sustained high calcium concentration over time, have shown 
different force behavior which cannot be explained with the model described in 
Chapter 3 and Chapter 4. 
Ozaki et al. (1991a) showed that the relationship between Ca
2+
, MLC phosphorylation 
and force changes as a function of [Ca
2+
]i in canine antral SMCs. In Figure 5.1, an 
external solution with 59.5 mM of KCl caused an increase in Ca
2+
 and tension. While 
the [Ca
2+
]i reached a relatively stable phase with only a slow decline after reaching its 
maximum value, the muscle tension reached a maximum level and relaxed to the 
resting state before the decline in [Ca
2+
]i. During the slow decline in [Ca
2+
]i, muscle 
tension reached its maximum value and declined more rapidly. This suggests that the 
[Ca
2+





Figure 5.1. Experimental result from canine antral smooth muscle showing a 
sustained maintenance of high calcium concentration as a result of elevated K+ in 
the external solution (Ozaki et al., 1991a).  The experimental result showed 
muscle tension declining rapidly after reaching a peak in comparison to a slowly 
declining Ca2+ and relaxed to the resting state much before [Ca2+]i reached its 
resting value. 
 
Previous studies have shown that regulation of calcium sensitivity is predominantly 
achieved through agonists and is caused by the regulatory pathways mediated by the 
agonists. However, Yagi et al. demonstrated that [Ca
2+
]i sensitivity decreased 
spontaneously with time (Yagi et al., 1988). Himpens et al. showed that [Ca
2+
]i 
sensitivity also changed during stimulation with a high K
+
 solution (Himpens et al., 
1988; Himpens and Somlyo, 1988; Himpens et al., 1989). Ozaki et al. has also shown 
that modulation in [Ca
2+
]i sensitivity occurred independently of agonist stimulation, 
during depolarization by elevated external K
+
 or other exogenous stimuli (Ozaki et al., 
1991a; Ozaki et al., 1992). Thus it appears that the sensitivity of the contractile 
response is dynamically altered depending on the [Ca
2+
]i signal irrespective of the 





]i sensitization was observed to be time dependent and depends on the rate of 
change of [Ca
2+
]i (Ozaki et al., 1991a). During rapid changes in calcium, as observed 
during spontaneous activity, a steep relationship between [Ca
2+
]i and force was 
observed (Ozaki et al., 1991a; Ozaki et al., 1993). However, during slow changes in 
[Ca
2+
]i, calcium desensitization occurred and caused a decrease in force. These 
observations lead to the hypothesis that one or more [Ca
2+
]i desensitizing 
mechanism(s) are activated when there is a slow change in [Ca
2+
]i. 
To understand if myosin phosphorylation is also involved in this feedback mechanism, 
MLC phosphorylation was measured with respect to [Ca
2+
]i (Himpens et al., 1988; 
Ozaki et al., 1991a; Ozaki et al., 1993). Changes in MLC phosphorylation were 
closely correlated with the change in muscle tension rather than the change in [Ca
2+
]i. 
The rate of relaxation and dephosphorylation were faster than the decay rate of 
calcium. This implies that the desensitization mechanism is related to or rather 
regulates myosin phosphorylation. During rapid calcium transients, the shift in the 
activation-inactivation mechanism contributes to the phasic behavior. During an 
increase in [Ca
2+
]i, the activation mechanisms cause contraction and during [Ca
2+
]i 
decrease, the inactivation mechanisms become predominant and cause relaxation.  As 
discussed in Chapters 3 and 4, the ratio of activities of MLCK and MLCP influence 
the level of myosin phosphorylation and hence the active force (Gong et al., 1992a).  
The regulation of this ratio by any change in MLCK activity, MLCP activity, or both, 
can lead to the observed behavior of myosin phosphorylation and force. One potential 
Ca
2+
 desensitizing mechanism reported in the literature is the Ca
2+
/CaM dependent 
protein kinase II (CaMKII) regulated phosphorylation of MLCK (Tansey et al., 1992; 
Stull et al., 1993; Tansey et al., 1994; Word et al., 1994; Murahashi et al., 1999).  
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5.2. Hypothesis 1 – Calcium desensitization through MLCK 
phosphorylation 
Purified myosin light chain kinase is phosphorylated at a specific serine site A (serine 
512) in the regulatory domain by activated Ca
2+
/CaM dependent protein kinase II 
(CaMKII) (Ikebe and Reardon, 1990). From peptide sequencing studies, the 
phosphorylation site is believed to be in proximity to the CaM binding site (Tansey et 
al., 1992). The phosphorylation of MLCK at the specific serine site has been found to 
result in reduced affinity of the enzyme for (Ca
2+
)4CaM and the dissociation constant 
(Kd) has been found to increase by approximately 25 times compared to the non-
phosphorylated MLCK (Kasturi et al., 1993; Hong et al., 2009). Non-phosphorylated 
MLCK is a high affinity target protein of CaM with a Kd approximately 1 nM and also 
CaM bound to MLCK has been shown to bind Ca
2+
 at its C-terminal site at a faster 
rate with enhanced affinity (Johnson et al., 1996).   
Goeckeler et al. (2000) and Conti et al. (1981) have identified and characterized more 
than one kinase with MLCK as one of their substrates. Their studies mainly point 
towards cAMP-dependent protein kinase, CaMKII and PKC. However the catalytic 
properties of the kinases have been reported to vary. Among the various kinases, 
CaMKII activation has been found to be dependent on (Ca
2+
)4CaM for its activation. 
Experiments done under calcium depleted conditions and KCl stimulation, have 
shown CaMKII activation to be Ca
2+
 dependent (Tansey et al., 1992; Tansey et al., 






Tansey et.al. (1994) showed that MLCK activity declined when the [Ca
2+
]i was 
increased in steps from 0.01 to 2 microM with each step at various intervals (30, 60 
and 120 seconds).  A significant observation was that MLCK phosphorylation 
happened at significantly greater Ca
2+
 concentrations compared to the Ca
2+
 
concentration required for MLCK activation. This was attributed to the greater 
concentration of (Ca
2+
)4CaM being required for activation of CaMKII relative to 
MLCK.  As [Ca
2+
]i was increased, activity ratio for MLCK decreased. The decrease 
was higher for the time interval of 60 seconds compared to 30 seconds after increasing 
[Ca
2+
]i. The MLCK activity ratios measured at 60 seconds and 120 seconds interval 
were the same indicating a steady state had been reached at 60 seconds. 
It has been shown that MLCK bound to CaM cannot be phosphorylated by CaMKII 
(Ikebe and Reardon, 1990; Tansey et al., 1992; Tansey et al., 1994). Hence it is 
possible that under the condition where MLCK is in excess to a limited level of free 
CaM, the free unbound MLCK is phosphorylated by activated CaMKII. With a high 
Ca
2+
 concentration, CaMKII would be in competition with MLCK for binding to 
(Ca
2+
)4CaM. In addition, phosphorylation of MLCK reduces its affinity for 
(Ca
2+
)4CaM, allowing for more (Ca
2+
)4CaM to be bound to CaMKII (Kasturi et al., 
1993; Hong et al., 2009). Hence phosphorylation of the unbound MLCK would alter 
the activation dynamics of the myosin light chain kinase and subsequently affect the 
level of myosin phosphorylation.  
CaMKII activation is known to be Ca
2+
 dependent and the observed phosphorylation 
of MLCK by CaMKII has been widely hypothesized to be a Ca
2+
 dependent negative 
feedback loop on MLCK activation and hence MLC20 phosphorylation (Stull et al., 
1993; Tansey et al., 1994). Hence the mechanism of MLCK phosphorylation has been 
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integrated with the main pathway model (Chapter 3) to test the hypothesis that MLCK 
phosphorylation alters the Ca
2+
 sensitivity of force at high Ca
2+
 concentrations. Two 
Ca
2+
 signals (Figure 5.1 and Figure 5.11) reported in the experimental work of Ozaki 
et al. (1991a) have been used as inputs to the model to observe the dynamics of 
MLCK activation in the presence and absence of MLCK phosphorylation. The 
objective here is to show that MLCK phosphorylation could be a possible mechanism 
for Ca
2+




5.2.1. MLCK phosphorylation pathway 
The reaction pathway that describes the Ca
2+
 dependent phosphorylation of MLCK is 
shown in Figure 5.2. The section of the Figure 5.2 in red shows the reactions leading 
to MLCK phosphorylation that has been added to the model to account for calcium 
desensitization at higher [Ca
2+





     
 
The approach reported by Lukas (2004b) was used to model the Ca
2+
 dependent 
phosphorylation of MLCK. In this model, the parameters of the enzyme kinetics of 





Figure 5.3. Reaction scheme showing phosphorylation of MLCK catalysed by the 










Figure 5.2. Reaction scheme showing phosphorylation of MLCK catalysed by CaMKII 
and binding of phosphorylated MLCK to (Ca2+)4CaM. 
Ca2+ CaMfree 
CaMKII 

















Using mass action kinetics, the reaction scheme shown in Figure 5.3 was defined by 
the Equation 5.1. The forward reaction with rate constant Kfwd defining the 




        
  
                             
                                      
    
         
                    
(5.1) 
 
                 
      
   
          
                    y1 and y2 are the parameters 
determining the Ca
2+ 
dependence of MLCK phosphorylation. CaMKII activation by 
increase in Ca
2+
 is represented by the parameter Vmax. Increase in [Ca
2+
]i, in addition 
to causing MLCK activation (Module I) also leads to phosphorylation of MLCK as 
shown in Figure 5.3.  Phosphorylated MLCK then binds to (Ca
2+
)4CaM as shown in 
the reaction scheme in Figure 5.4 to form (Ca
2+
)4CaM-MLCKp. In the absence of 
experimental data on the dephosphorylation kinetics of MLCK, the dephosphorylation 














Figure 5.4. Reaction scheme showing binding of phosphorylated MLCK to (Ca2+)4CaM. 
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(5.2) 
 
Equations 5.1 and 5.2 define the negative feedback mechanism due to MLCK 
phosphorylation. At higher calcium concentrations, MLCK phosphorylation will be 
driven forward, as shown in Figure 5.3, and the phosphorylated MLCK binds to  
(Ca
2+
)4CaM (Figure 5.4) with reduced affinity as compared to unphosphorylated 
MLCK. The values of the parameters were estimated by fitting to experimental result 
shown in Figure 5.1 and the resulting values are reported in Table 5.1. 
 
Table 5.1. Parameters involved in the MLCK phosphorylation pathway described by 
Equations 5.2 and 5.3. 
Reaction Parameters Ref 
MLCK ↔ MLCKp 
y1 = 3 s
-1
 
y2 = 0.6 µM 
Km = 0.5 µM 






)4CaM  ↔ (Ca
2+
)4CaM-MLCKp 





Krev  = 0.1 s
-1
 
(Johnson et al., 
1996; Lukas, 




5.2.2. Results and Discussion 
Figure 5.1 shows the contractile behavior of canine antral SM when intracellular 
[Ca
2+





rapidly, reached a maximum within 1 minute and reached a plateau like phase with a 
slow decay rate for around five minutes. Muscle tension also increased, reached a 




The model was simulated with the [Ca
2+
]i input signal shown in Figure 5.1. The force 
behavior predicted by the model is given in Figure 5.5.  In the experimental result 
shown in Figure 5.1, the maximum force value attained during the plateau like slow 
declining phase of [Ca
2+
]i was 5 times the peak force value achieved during the initial 
rapid Ca
2+
 transients. Without MLCK phosphorylation, the model predicted a 
maximum force value 29 times the peak force value achieved during rapid Ca
2+
 
transient (Figure 5.5A). However in the presence of MLCK phosphorylation, the 
maximum force value produced decreased to 13 times the peak force value in the 
initial the rapid Ca
2+
 transient (Figure 5.5B). This shows that MLCK phosphorylation 
did indeed reduce the force reponse to Ca
2+
 at high Ca
2+
 levels as seen in Figure 5.5. 
In terms of the temporal response and shape, the results from the model with MLCK 
phosphorylation showed better qualitative agreement with experimental force 
behavior compared to the model without MLCK phosphorylation. The rate of force 
development during the induced Ca
2+
 transient (from one to six minutes in Figure 5.5) 
was slower in the model with MLCK phosphorylation compared to the model without 






    
    
 
Figure 5.5. Effect of MLCK phosphorylation on the simulated force behavior for 
a given [Ca2+]i signal. A) Normalized force (N) produced by the model without 
MLCK phosphorylation, B) Normalized force (N) produced by the model in the 
presence of MLCK phosphorylation mechanism and C) &D) Normalized force is 
shown as fraction of maximum value in the absence and presence of MLCK 
phosphorylation mechanism respectively. MLCK phosphorylation leads to 
desensitization producing less force at high [Ca2+]i levels with no significant 
effect on the response to rapid Ca2+ transients. 
 
 





























































































































The force response in the presence of MLCK phosphorylation can be attributed to the 





shown in Figure 5.6B. In the presence of high sustained Ca
2+
, MLCK is 
phosphorylated as shown in Figure 5.6A. MLCK binds to (Ca
2+
)4CaM rapidly while 
MLCKp binds to (Ca
2+
)4CaM with reduced affinity. Phosphorylation causes a shift in 
the Ca
2+
 sensitivity of MLCK by reducing its affinity to (Ca
2+
)4CaM. This is shown by 
the time lag in the formation of the (Ca
2+
)4CaM-MLCKp complex. It was noted that 
MLCK phosphorylation and formation of (Ca
2+
)4CaM-MLCKp are not significant 
during the rapid Ca
2+
 transients.  
 
 
Figure 5.6. Effect of MLCK phosphorylation mechanism on the activation of 
MLCK. A) MLCK phosphorylation (solid line) and B) formation (Ca2+)4CaM-
MLCK (solid line) and (Ca2+)4CaM-MLCKp (dashed line) for a given Ca
2+  signal 
(dotted line) are shown. Ca2+ dependent MLCK phosphorylation and reduced 
affinity of phosphorylated MLCK to (Ca2+)4CaM leads to slow formation of 
(Ca2+)4CaM-MLCKp compared to the rapid formation of (Ca
2+)4CaM-MLCK. 
 
Figure 5.7 shows the effect of MLCK phosphorylation mechanism on the activation of 
MLCK. At sustained high Ca
2+
 levels, phosphorylation of MLCK leads to lower levels 
of MLCK activation. 



































































































Figure 5.7. Effect of myosin phosphorylation on MLCK activation at sustained 
high Ca2+ concentration. Concentration of MLCKactive complex as a percentage of 
total MLCK for a given Ca
2+
 input shown in Figure 5.6 is shown in the presence 
(solid line) and absence (dashed line) of MLCK phosphorylation mechanism. It 
can be seen that MLCK phosphorylation affects both the magnitude and temporal 
dynamics of MLCK activation. 
 
It should be noted here that reduced affinity of phosphorylated MLCK becomes 
important under the condition of limited free intracellular CaM and competitive 
binding of other high affinity target proteins to CaM. MLCK cannot be 
phosphorylated at the regulatory site by a kinase when it is bound to CaM. If there is 
excess CaM, it would inhibit MLCK phosphorylation by binding to MLCK. Hence the 
hypothesis presented here would not hold under the condition of excess free CaM. If 
free intracellular CaM is present in limited levels, as has been shown by experimental 
studies (Persechini and Stemmer, 2002), the model predictions indicate that MLCK 
phosphorylation regulates the Ca
2+
 sensitivity of MLC20 phosphorylation and hence 








































force production in SMCs. The distribution and concentration of CaM and MLCK 
(free vs. bound) is important in this regulation. Thus according to this model, Ca
2+
 
positively regulates MLC20 phosphorylation via MLCK activation and negatively 
regulates MLC20 phosphorylation via activation of CaMKII and down regulation of 
MLCK activation at higher Ca
2+
 levels. According to Tansey et al. (1994), this model 
represents a unique cellular mechanism that involves a decrease in Ca
2+
 sensitivity 
rather than a decrease in Ca
2+
 per se. 
The model results support the hypothesis that MLCK phosphorylation, by acting as a 
negative control mechanism for myosin light chain phosphorylation, affects the 
contractile response. The Ca
2+
 activation properties of MLCK regulate the myosin 
light chain phosphorylation. The activation properties of MLCK are in turn regulated 
by the Ca
2+
 activation properties of CaMKII which phosphorylates MLCK.  There is 
notable lack of data for the Ca
2+
 activation properties of CaMKII in smooth muscle 
cells. Once the data becomes available, the model can be extended to include the 
CaMKII activation pathway. 
At present the dephosphorylation of MLCK has been modelled with a fixed rate 
constant due to the lack of data on dephosphorylation kinetics of MLCK. However in 
vitro studies have shown that type 2A protein phosphatase and type 1 protein 
phosphatase were able to dephosphorylate MLCK at specific sites (Nomura et al., 
1992). A protein phosphatase fraction isolated from smooth muscle actomyosin was 
characterized to contain multiple protein phosphatases capable of dephosphorylating 
phosphorylated MLCK with unique site specificities and catalytic properties. The 
isolation of such protein phosphatase shows that the phosphatases could possibly have 
an effect on the regulation of the activity of MLCK. These findings open new avenues 
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for investigation of the role of various phosphatases in contraction of SMCs. Once 
kinetic data on dephosphorylation of MLCK is available, the current model can be 
improved by replacing the fixed dephosphorylation rate constant with suitable enzyme 
kinetic reaction. 
Though many biochemical studies have been done on the phosphorylation of MLCK 
by CaMKII, only limited data is available on the quantitative relationship between 
calcium and active force generation relative to MLC20 phosphorylation with and 
without MLCK phosphorylation (Tansey et al., 1994). Hence a pathway model with 
MLCK phosphorylation such as this one would be useful to predict the effect of 
MLCK phosphorylation on myosin phosphorylation and active force. 
 
5.3. Hypothesis 2 – Calcium desensitization through MLCP 
activation 
MLCK phosphorylation caused desensitization of force to a sustained [Ca
2+
]i signal 
the relaxation was more rapid in the experimental results (Figure 5.1) compared to the 
model predictions (Figure 5.5). The regulation of MLCP and its activation by smooth 
muscle specific protein telokin was discussed in the previous chapter (Chapter 4). 
Biochemical studies have identified phosphorylation sites on telokin and 
phosphorylation of telokin at a specific serine site (serine 13) by cellular kinases such 
as the cyclic nucleotide-activated protein kinase(s) has been suggested to enhance its 
ability to increase the activity of MLCP (Wu et al., 1998; Krymsky et al., 2001; 
Walker et al., 2001; Choudhury et al., 2004).  Addition of phosphorylated 
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recombinant telokin has been shown to be more potent in inducing relaxation than 
non-phosphorylated telokin (Khromov et al., 2006). 
It has also been suggested that active MLCK causes slow phosphorylation of telokin 
(Sobieszek et al., 2005; Hong et al., 2009). Hence it is possible that under high and 
sustained [Ca
2+
]i conditions, phosphorylation of telokin causes increased activation of 
MLCP leading to desensitization to Ca
2+
.  Given that telokin can be phosphorylated 
and phosphorylated telokin is a more potent relaxing agent, it appears that this may be 
a possible mechanism for [Ca
2+
]i desensitization. Hence enhanced activation of MLCP 
is hypothesized as a mechanism for calcium desensitization in phasic SMCs. 
 
5.3.1. Enhanced MLCP activation model 
The slow activation of MLCP in response to a sustained maintenance of high calcium 
concentration was modelled with the same approach as used for the MLCP activation 
during a rapid Ca
2+
 transient as shown in Equation 5.3.  
       
  
                   
                 (5.3) 
 
The parameters control the concentration of MLCP, with A2 controlling the amplitude 
of activation and ω2 (=1/τ) representing the time constant of MLCP activation.  
∆[MLCP] on the right hand side of the Equation 5.3 is the concentration of MLCP in 
response to the normal rapid calcium transients defined by different set of parameters 
(Section 4.3) and shows the activation of MLCP by telokin under normal calcium 
transients. The parameters A2 and ω2 describe the enhancement in the activation of 
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MLCP i.e., more MLCP is activated by phosphorylated telokin with slower kinetics in 
addition to the MLCP activation described in Section 4.3. This method was used due 
to the unavailability of experimental data regarding the exact mechanism of activation 
of MLCP by telokin and quantitative details on the phosphorylation of telokin and 
enhancement of the activation ability of telokin upon its phosphorylation.  The 
parameter values were estimated by fitting the model to the experimental force curve 
shown in Figure 5.1.  A limiting condition of total MLCP equal to total MLCK (10 
µM) was assumed in the estimation of the parameters. The estimated values of A2 and 




5.3.2. Results and Discussion 
A slow decline in [Ca
2+
]i leads to slow enhancement in the activation of MLCP as 
shown in Figure 5.8.   
The effect of the enhanced activation was not significant during rapid Ca
2+
 transients. 
A 14.7% increase in [MLCP] during the slow declining phase of [Ca
2+
]i decreased the 
magnitude of maximum force achieved by 10% compared to the maximum force 
achieved without the enhanced MLCP activation shown in Figure 5.9A. Normalized 
force from the model with and without the enhanced MLCP activation mechanism are 
expressed as a fraction of their maximum value to compare the temporal dynamics of 







Figure 5.8. Concentration of MLCP for a given Ca2+ signal (dotted line) in the 
presence (solid line) and absence (dashed line) of the enhanced MLCP activation 
reaction (Equation 5.3). 
 
 
          
Figure 5.9. Effect of enhanced MLCP activation on the normalized force behavior for 
a given Ca2+ signal (dotted line). Enhanced MLCP activation caused further 
desensitization by decreasing the magnitude of maximum force achieved by 10% as 
shown in (A) and did not have any significant effect on the temporal dynamics of the 
force behavior as seen in (B). 
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The extended model with MLCK phosphorylation and enhanced MLCP activation 
was simulated with a prescribed rapid Ca
2+
 transient with a [Ca
2+
]max of 0.3 µM and 
the results are shown in Figure 5.10. The presence of desensitization mechanism 
reduced the amplitude of the peak force and did not have a significant effect on the 
temporal dynamics of the force behavior for the rapid Ca
2+ 
transient. With a prescribed 
rapid Ca
2+
 transient with a [Ca
2+
]max of 0.8 µM, normalized force of 11% was 
achieved. As suggested by Word et al. (1994) and Yagi et al. (1988), the desensitizing 
mechanims can be attributed to the dissociation in the coupling of [Ca
2+
]i and force 
production observed during the activation of single gastric smooth muscle cells. 
 
  
Figure 5.10. Simulated normalized force behavior for a prescribed Ca2+ transient 
(dotted line). The presence of desensitization mechanisms reduced the amplitude 
of the peak force as seen in (A) and did not have a significant effect on the 
temporal dynamics of the force behavior as seen in (B). 
   
The model was also tested with an another [Ca
2+
]i input signal reported by Ozaki et al. 
(1991a) (Figure 5.11). In Figure 5.11, Ca
2+
 depletion in the external solution with 
EGTA caused decrease of Ca
2+
 below the resting levels. However the tension did not 
decrease and was maintained at the resting state. Addition of Ca
2+
 to the external 




































































solution progressively caused an increase in [Ca
2+
]i and restored the contractions. It 
should be noted that contraction was initiated below the initial resting Ca
2+
 value. 
Ozaki et al. (1991a and 1993) has argued that the threshold for contraction depends on 
the basal resting [Ca
2+
]i condition. A decrease in resting [Ca
2+
]i caused a decrease in 
the [Ca
2+
]i threshold for contraction due to a change in Ca
2+
 sensitivity as shown in 
Figure 5.11. Cumulative addition of [Ca
2+
]i further increased intracellular [Ca
2+
]i and 
subsequently muscle tension. However the the fall in tension preceded the fall in 
[Ca
2+
]i. Similar results have also been reported in ileal SM (Himpens et al., 1988; 
Himpens et al., 1989). These results show that the contractile response gets 
desensitized or sensitized to Ca
2+




Figure 5.11. Experimental results from canine antral smooth muscle showing 
changes in Ca2+ and muscle tension in response to Ca2+ depletion and re-addition. 
 
The experimental maximum force value attained was 2 times the peak force value of 
the rapid Ca
2+
 transient. Without any desensitizing mechanisms, the model predicted a 
maximum force value 17 times the peak force value achieved during rapid Ca
2+
 
transient (Figure 5.12). However in the presence of desensitizing mechanisms, the 
maximum force value produced was only 9 times the peak force value corresponding 
to the rapid Ca
2+
 transient (Figure 5.12). Though exact quantitative match to 
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experimental result could not be achieved at this stage, it is evident that the two 
mechanisms, MLCK phosphorylation and MLCP activation, act as negative feedback 
controls and cause desensitization to Ca
2+
. 
Ozaki et al. (1991a) suggested that the Ca
2+
 desensitization observed was time 
dependent. During the relatively rapid increases of [Ca
2+
]i, there is a steep relationship 
between Ca
2+





 depolarizations lead to activation of desensitizing mechanisms that 
diminish the contractile response for a given increase in [Ca
2+
]i (Ozaki et al., 1991a). 
Ozaki et al. (1991a) has argued that a shift in the activation-inactivation balance 
during the slow declining phase of [Ca
2+
]i leads to the observed force behavior.  
In the current model, rapid increase in [Ca
2+
]i leads to rapid MLCK activation and 
initiation of contraction. When [Ca
2+
]i reaches a plateau like slow declining phase, 
phosphorylation of MLCK and enhanced activation of MLCP are induced. While 
MLCK phosphorylation reduces the activation rate of MLCK and hence myosin light 
chain phosphorylation, higher MLCP activation levels accelerate myosin light chain 








Figure 5.12.Simulated normalized force for a given experimental Ca2+ signal 
(dotted line) in the presence (solid line) and absence (dashed line) of 
desensitizing mechanisms. Without any desensitizing mechanisms , the model 
predicted a maximum force value 17 times the peak force value achieved during 
rapid Ca2+ transient. However in the presence of desensitizing mechanisms, the 
maximum force value produced was only 9 times the peak force value 
corresponding to the rapid Ca2+ transient. This indicates the desensitization of 
force to Ca2+. 
 
 
Figure 5.13. Simulated normalized force for a given experimental Ca2+ signal 
(dotted line), expressed as a fraction of the maximum value, in the presence 
(solid line) and absence (dashed line) of desensitizing mechanisms. The figure 
shows the effect of the desensitizing mechanisms on the temporal dynamics of 
force behavior. 




































































Though MLCK activation is the primary mechanism in the active force production in 
SMC, the results reported here suggest that the relationship between Ca
2+
 and active 
force may be subject to secondary regulation from an extended network of kinases and 
phosphatases. Activation of desensitization processes is evident from the experimental 
results. However, the exact molecular mechanisms are not yet clear. From the various 
pathways and molecular species observed in vitro, only suggestive claims have been 
made on what could be the mechanism of calcium desensitization. Work done by 
Tansey et al. (1992 and 1994), Stull et al. (1993) and Word et al. (1994) support the 
hypothesis that the regulation of MLCK through its phosphorylation regulates the 
Ca
2+
 sensitivity of force in phasic SMCs. Ozaki et al. (1991a) and Choudhury et al. 
(2004), suggest that MLCP activation leads to Ca
2+
 desensitization in phasic smooth 
muscles. Hence one or more pathways could be acting in tandem or separately in vivo 
to cause the calcium desensitization. Events related to filament re-organization have 
also been reported to play role in the calcium sensitization process (Murahashi et al., 
1999). It has been suggested that dynamic changes in the actin cytoskeleton regulate 
the development of mechanical tension and the material properties of smooth muscle 
cells. Actin polymerization has been found to affect the muscle tension by increasing 
the number or stiffness of attachments of actomyosin assemblies to membrane-dense 
plaques and cytoplasmic-dense bodies (Gerthoffer and Gunst, 2001). Cytoskeletal 
remodeling and mechanotransduction pathways regulated by various cellular proteins 
like integrins, focal adhesion kinase (FAK), and small heat shock protein (HSP27) 
have been found to mediate adaptive responses of the SM cytoskeleton to various 
stimuli (Gunst  and Zhang, 2008). 
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 desensitization have 
been identified from the literature and quantitatively described. First one is the 
phosphorylation of MLCK by CaMKII and the second mechanism is the enhanced 
MLCP activation by phosphorylated telokin. The two mechanisms have been shown 
to reduce the force response to a given [Ca
2+
]i and can be attributed to the 
desensitization phenomenon observed in phasic smooth muscle cells.  
There is convincing evidence in the literature that Ca
2+
-CaM mediated MLCK 
activation and the resultant myosin light chain phosphorylation is the central 
mechanism in active contraction of SMC. Gene knockout studies and studies with 
specific inhibitory agents (e.g., wortmannin) have established the role of MLCK in the 
overall cell function (Burke et al., 1996; He et al., 2008). Targeted deletion of MLCK 
in adult mouse smooth muscle resulted in severe gut dysmotility characterized by 
weak peristalsis, dilation of the digestive tract and reduction of faeces excretion and 
food intake (He et al., 2008). These studies establish the significance of a cellular 
reaction in the physiological context. However, there is no conclusive evidence for the 
role of Ca
2+
 desensitizing mechanisms in the physiological setting. Whole cell and 
tissue level experiments have shown the presence of a phenomenon called Ca
2+
 
desensitization. From the observation that MLCK is being phosphorylation by cellular 
kinases and MLCK phosphorylation regulates its activation negatively, it has been 
hypothesized to be a Ca
2+
 desensitizing mechanism. More studies are still required to 






The main aim of this thesis was to investigate the relationship between intracellular 
Ca
2+
 concentration and force in gastric SMCs. By describing the biochemical 
reactions linking Ca
2+
 to contraction, the phasic contractile behavior of gastric SMCs 
has been simulated. The simulation results have been compared to experimental 
recordings and good qualitative agreement has been found. The various modules of 
the model and their effect on the force response capture their regulatory role in the 
smooth muscle cell function. This model has accounted for the specific properties of 
SMCs exhibiting phasic contractile behavior.  
A pathway for active contraction has been developed and quantitatively described. In 
this modelling study, data from isolated experiments have been collated and placed in 
a physiologically relevant scheme. This thesis in addition to contributing towards an 
in silico model which will serve as a useful tool for understanding gastric physiology 
in health and disease, also helps to identify the key areas where further experimental 
investigation is needed for a better understanding of the problem. 
In the multiscale modelling of GI system, a cellular level model for SM contraction 
would play a significant role in the development of tissue level and organ scale 
models to study gastric motility. Although generic models of SM contraction and 
models for other SM types (e.g., airway, vascular which are primarily tonic SM) have 
been developed previously, this study has led to a model that is specific for phasic 
gastric SM. MLCP regulation by telokin has been modelled for the first time. MLCK 
phosphorylation and MLCP activation pathways have been investigated in a 
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physiological context of Ca
2+
 desensitization and the regulatory effect of kinase-
phosphatase network on the active contractile response of a SMC has been discussed. 
 
6.1. Limitations and Future Work 
In the model, actual force values are not estimated. What is being estimated is the 
number of cross bridges for a given total myosin concentration. Gestrelius and 
Borgstrom (Gestrelius and Borgstrom, 1986) have proposed a formulation for active 
force as a function of normalized number of cross-bridges available for interaction 
with actin, the stiffness of a cross-bridge and average cross-bridge extension 
(Equation 2.8).  Such a mathematical formulation to calculate active force from the 
number of cross-bridges is necessary to validate the model against experimental force 
data without any normalization. Existing literature on the mechanical properties of 
cross-bridge will be useful for this purpose. 
Based on literature evidence and to account for the rapid decline of force in the 
experimental results compared to model predictions, MLCP regulation was included 
in the model. Though MLCP regulation has been widely reported in the literature, 
there are no quantitative reports on cellular concentration of MLCP and kinetic studies 
on its regulatory pathways. Hence a biochemical reaction based approach similar to 
MLCK activation pathway could not be drawn for MLCP regulation. A bottom up 
approach of predicting MLCP behavior from the force behavior was used and a 
feedback equation based on electronic filters was hypothesized. Once the reaction 
scheme for telokin mediated MLCP activation is available, the feedback equation can 
be replaced with the reaction kinetics. 
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Dephosphorylation of MLCK (Chapter 5) has been modelled with a fixed rate 
constant. Though some studies have identified cellular phosphatases 
dephosphorylating phosphorylated MLCK, quantitative properties of the phosphatases 
are still unknown (Nomura et al., 1992). With further characterization of MLCK 
specific phosphatases, the dephosphorylation kinetics in Equation 5.1 can be modelled 
with phosphatase enzyme kinetics. 
In the estimation of the parameter values, one of the two scenarios, either problem of 
over fitting or under-constrained estimation can arise. In this study, over-fitting of the 
model was not possible due to limited GI specific data. The problem of under-
constrained estimation was avoided by using suitable data from other cells types 
where GI specific data was not available. For example, module I was predominantly 
fitted using data from HEK cells. However Module II has been built and validated 
using canine gastric antrum SM data. Experimental data from human GI SM will 
hopefully be available in the future and enable human GI specific models. 
The most important future work would be to integrate this model to electrical models 
of GI SM and use it in tissue and organ level descriptions to study GI motility. The 
motivation for the work also stems from multiscale modelling studies done to study 
the electrical activity throughout the stomach and the experimental studies on 
contractile response for a given electrical stimuli. To understand how electrical 
activity regulates the motility function in GI, the intracellular Ca
2+
 profile from 
experimental studies and electrical models have to be linked to contraction. Integrative 
models at different levels of biological organisation, from genes to the whole 
organism via gene regulatory networks, protein pathways, cell function, and tissue and 
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Equations in the model 
1. Module I : Model for Ca2+ dependent MLCK activation 
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2. Module II : Model for myosin phosphorylation and cross-bridge formation 
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3. Input calcium transient 




                                                                                                          
             
          
     
    
     
                        
             
          
      





4. MLCP regulation model 
 
       
  
                       
 
 
5. Model for Ca2+ induced Ca2+ desensitization 
5.1. MLCK phosphorylation model 
Reaction Equation 
MLCK  ↔ MLCKp 
        
  
                             
                                    
    
         
                    
 
                 
      
   
          




(Ca2+)4CaM  ↔ 
(Ca2+)4CaM-MLCKp 
                   
  
                   
        
          





5.2. Enhanced MLCP activation model 
        
  
                   
                
                                   






Values of the model parameters 














1 2.3 2.4 1.043 
2 160 500 3.125 






















10 2.3 0.39 0.1696 




Note: *- parameters estimated through fitting.
 #
- the parameter calculated from the 
















kcat _MLCP 30 s
-1
 




[MLCP] 7.703 µM 
 
 




]r 0.1 µM 
[Ca
2+
]max 0.6 µM 
t1 0 s 
t2 2 s 





4. MLCP regulation model 






5. Model for Ca2+ induced Ca2+ desensitization 
 
5.1. MLCK phosphorylation model 
Reaction Parameters 
MLCK ↔ MLCKp 
y1 = 3 s
-1
 
y2 = 0.6 µM 
Km = 0.5 µM 





)4CaM  ↔ (Ca
2+
)4CaM-MLCKp 










5.2. Enhanced MLCP activation model 






6. Steady state concentration of the species at resting Ca2+ concentration of 0.1 
µM. 
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